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 Bone marrow cells are considered as the prominent cell 
source for clinical application to injuries and degenerative 
diseases. For cell-based therapies, the optimal cell source must 
be readily accessible with easily isolated and large-scale 
expanded cells maintenance is important for clinical application. 
Optimizing manipulation protocol of chicken bone marrow cells 
have not been reported because of their heterogeneous 
phenotype and mixed cell population. In this study, I conducted a 
study on the cell characteristics and the culture environment for 
a mass culture environment using chicken Sox9 positive cells. 
And the possibility of applying the treatment confirmed through 
consideration of the application in terms of regenerative medicine 
using the cell secretions. 
 
 First, I observed the histology of the long bone and 
cellular properties of bone marrow cells retrieved from 4-day-
old neonatal chicks. Long bones, such as the femur, have been a 
major source of bone marrow cells in which endochondral 
ossification is responsible for bone formation. Histology, cell 
culture outcomes, specific marker expression, and differentiation 
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potential were evaluated the academic and industrial feasibility 
of chick bone marrow cells as a new biomaterial. The results of 
this study clearly demonstrated that bone marrow tissue of 
neonatal chicks was premature at least up to 4 days after 
hatching. This tissue contains a variety of cells involved in 
endochondral ossification as well as mature bone marrow cells. 
The majority of these cells became cuboidal until the end of 
primary culture, and more than 80% of cells were Sox9-positive. 
The results of the osteogenic and chondrogenic differentiation 
ability suggest the feasibility of Sox9 for regenerating bone 
marrow tissues. 
 
 Next, I investigated the necessity culture regime for 
enhancing cell maintenance, expanding the Sox9-rich neonatal 
bone marrow cells and differentiation through a suspended 
culture. Neonatal bone marrow cells retrieved from 4-day-old 
white leghorn (WL) were subcultured in high glucose DMEM, low 
glucose DMEM or DMEM/F12. Use of DMEM/F12 as a basic 
medium for chicken bone marrow cell culture was found suitable 
for the culture environment from the results of this study. In 
retrieved cells from 4-day-old chicken, osteogenic and 
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chondrogenic related gene expression were expressed 
regardless types of culture media. But, changing of basic medium 
to DMEM/F12 mainly serves as the activator of cell proliferation. 
Also, this beneficial function directly enhances osteogenic or 
chondrogenic differentiations potential of sox9 positive cells 
using DMEM/F12 media although mixed population of the cells 
involving endochondral ossification. In conclusion, the 4-day-
old chicken bone marrow cells culture in vitro amplifies Sox9- 
and Col II-positive cells, and optimized culture environment of 
DMEM/F12 was useful for customizing culture regime for cell 
maintenance and differentiation. 
 
 Third study is the analysis on effectiveness of basic 
fibroblast growth factor (bFGF) and stem cell culture medium 
like primordial germ cell (PGC) culture media for expanding 
germness and pluripotent related expression. First, In 
DMEM/F12 culture media with different concentrations of bFGF 
(0ng/ml, 1ng/ml, 5ng/ml, 10ng/ml) are added to the optimized 
sox9 positive cell culture medium. Basic fibroblast growth factor 
(bFGF) is a member of the FGF family and is a critical component 
of stem cell culture field. However, the role and optimized 
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concentration of bFGF on promoting the chicken derived sox9 
positive cells has not been reported. To monitor the influence of 
bFGF on retrieved cells in vitro, proliferative capacity, cell 
morphology, gene expression, immunophenotype and 
differentiation potential and functional tests like cell migration 
and invasion assay were evaluated as experimental parameters. 
Second, the PCG culture medium is similar to the medium 
condition of embryonic stem cells, which has been amplification 
of the germness and pluripotent gene expression of primary cells 
in 4-day-old whole bone marrow. In conclusion, the results of 
this study suggested that addition of 5 ng/ml bFGF in vitro on 
sox9 positive cells was effective for proliferation, differentiation, 
migration and invasion ability. Also using PGC media for culture 
of isolated cells shows different cell characteristics. In cell 
specific marker expression, stromal cell marker (CD44) 
expressed on PGC culture media and in differentiation assay 
shows adipogenic differentiation ability on PGC medium cultured 
cell population. 
 
Finally, I applied putative bioactive substances substance 
to human adipose derived mesenchymal stromal cells (hADSC) 
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that is the origin of cell secretion and explored the effect of 
regenerative medicine such as bone differentiation potential. 
Bone marrow cells from four-day-old white leghorn chicks 
differentiated into osteogenic lineages. After 3weeks 
differentiation time, media changes serum-free fresh culture 
media. These Collected media were concentrated until total 
protein concentration reached to 50, 100 or 200 ug/ml. 
Using these concentration soup, osteogenesis was induced either 
by routine protocol or by the protocol using at different 
concentrations of total protein. From the results of this 
experimentation suggests that certain substrates secreted by 
chick bone marrow cells stimulate osteogenic differentiation of 
hADSCs. 
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 The chicken is a popular experimental model animal and 
research is underway in various fields (Davey and Tickle, 2007; 
Kain et al., 2014). As an experimental animal, chickens have the 
advantage of being easy to access and easy to manipulation 
(Cloney and Franz-Odendaal, 2015). However, in experiments 
with chickens, the lack of unusual markers like chicken specific 
antibodies can be seen as a disadvantage. Research on chickens 
has been conducted since the early 2000s. The study used over 
11 weeks old chickens and the isolated cells were typical 
morphology of the stromal cells (Wu et al., 2010b; Bai et al., 
2012). But my previous study showed that the properties of cells 
from 4-day-old chicken differed from the commonly known 
mesenchymal stem cells properties.  
 
The avian species like chickens, quails and pheasants have 
unique characteristics based on their evolutionary position 
between mammals and other species. Development stage is the 
most significant difference from mammals performing 
organogenic reproduction in the body, and relevant or additional 
differences are found in the process of embryonic production. In 
bone development stage, two different processes involve the 
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formation of the bones such as endochondral and 
intramembraneous ossifications play a pivotal role in inducing 
bone morphogenesis then differentiated into osteoblasts and 
chondrocytes (Shapiro, 2008; Zhang et al., 2011a). Endochondral 
ossification is responsible for the formation of the long bones 
such as the femurs and tibia. Cartilage tissue is formed prior to 
ossification, and subsequent ossification acquires the activities 
of rudimentary long bone formation, extension of its length and 
natural healing against various damages. Intramembranous 
ossification induces bone formation without cartilage 
development. In both process, bone formation is completed 
before birth, while the extension of bone length continues until 
puberty. In mammals, endochondral ossification was completed 
until the birth and primitive cells for ossification usually 
disappeared in neonatal offsprings. The long bones are the 
source of bone marrow cells, of which endochondral ossification 
following hypertrophic proliferation and calcium deposition 
occurs. 
 
Bone marrow-derived cells have an enormous value for 
the research on mesenchymal stems cell and cell transformation 
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(Pal and Das, 2017). In recent studies, mesenchymal-derived 
multipotent cells have become a valuable resource for cell-to-
tissue regeneration and experimental modelling for 
differentiation and reprogramming (Akiyama et al., 2012; 
Goldberg et al., 2017). Bone marrow cells are comprised of 
various undifferentiated progenitors and precursors, which could 
provide enormous information on cell differentiation using an ex 
vivo system (Tevlin et al., 2016). It can differentiate into multi 
lineages (Woodbury et al., 2002) such as bone, fat, cartilage, 
muscle, neuron and liver cells under differentiate culture 
condition in vitro (Pittenger et al., 1999; Campagnoli et al., 2001). 
Differentiation is controlled by specific genetic regulation 
pathway which can be induce into a specific lineage. Also 
induction chemicals, growth factors are accelerate appropriate 
differentiation, proliferation (Indrawattana et al., 2004; Kim et al., 
2005; Li et al., 2007). And bone marrow cells are considered as 
the basic material for clinical application to injuries and 
degenerative diseases (Chanda et al., 2010; Chu, 2015; Wang et 
al., 2016). For clinical implementation of bone marrow cells, their 
stable maintenance is important for optimizing manipulation 
protocol of bone marrow cells and the large-scale expanded 
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culture system has been necessary to high reproducibility of 
bone marrow cells. Also bone marrow-derived cells give rise to 
a hierarchy of cell population within the bone. In bone, it can be 
divided into several development stages on osteogenic and 
chondrogenic progenitor cells like osteochondro progenitor cell, 
preosteoblast, osteoblast, osteocytes, chondrocyte, proliferate 
chondrocyte and hypertrophic chondrocyte (Hofstetter et al., 
1991; Aubin, 2001). Osteochondral progenitor cells are located 
in the inner layer of the perichondrium, the inner layer of the 
periosteum, and in the endosteum. From these locations, they can 
be a potential source of new osteoblasts or chondroblasts. Also 
it can be differentiated into osteoblastic, chondroblast lineages 
(Friedenstein et al., 1966; Orlic et al., 2001; Toma et al., 2002; 
Morikawa et al., 2009). Osteochondro progenitor cells are very 
important for making a bone and cartilage. They can be found 
inner of the long bone and can be differentiated into osteoblast 
and chondrocyte. Isolation of a more homogeneous population of 
progenitors may be necessary for more efficacious study and 
adaptations on regenerative medicine. For using cells in a clinical 
application, cells can be easily isolation, accessible and abundant. 
As the fully differentiated bone and cartilage develops from 
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mesodermal lineages like mesenchymal stem cells that 
differentiate into osteochondro progenitors and finally 
differentiated into mature bone and chondrocytes.  
 
Especially, osteo/chondro progenitor cells are one of the 
kind of cells in bone marrow, which are also known as sox9 
positive cells. In osteo/chondro progenitor cells, Sox9 is a 
transcriptional factor that responsible for expression of Runx2 
(Leung et al., 2011; Chen et al., 2014; Loebel et al., 2015), 
Collagen related various type, aggrecan and the other multiple 
ECM related markers for differentiation into ostegenic and 
chondrogenic differentiations (Day et al., 2005; Nooeaid et al., 
2012). In osteogenic differentiation, differentiation medium 
consisting of culture media supplemented with dexamethasone, 
ß-glycerophosphate, ascorbic-2-phosphate was conducted to 
induce differentiation into osteoblast (Eslaminejad et al., 2013). 
And it can be demonstrated by calcium accumulation using 
Alizarin Red S (ARS) (Gregory et al., 2004). In chonrogenic 
differentiation, differentiation medium consisting of culture 
media supplemented with Insulin-transferrin-selenium x, 
bovine serum album, linoleic, ascorbic acid-2-phosphate, TGF-
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β1 (Joyce et al., 1990; Roark and Greer, 1994; Day et al., 2005; 
Kolambkar et al., 2007). And it can be demonstrated by formation 
of proteoglycan using alcian blue staining solution (Akiyama et 
al., 2002; Day et al., 2005).  
 
Over the past few years, many study groups have studied 
using conditioned media to evaluate efficiency as a generative 
biomarker. Released protein from conditioned media by cultured 
cells is a rich source of materials for biomarker as an application 
of novel treatment (Xue et al., 2008). Useful proteins released 
from cells culture medium can be used as novel bio-active 
substances to apply for the disease or regenerative treatment 
effects. This technique provides a useful, easy and effective 
method for discovering new biomarkers. The point here is that 
protein analysis is enhanced due to finding identification of 
biomarker candidate in which grown serum-free culture 
conditions (Righetti et al., 2003). Protein found in the medium 
controlled by the cell lines will come from cells through many 
different channels. The development of mass spectroscopy (MS), 
unlabeled techniques, LC systems, and biometrics approaches 
had a profound impact on protein dynamics (Wong et al., 2009). 
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These advances, combined with analysis of conditioned media, 
will undoubtedly facilitate identification of candidate biomarkers 
in cell culture environments. 
 
The standard procedure for the osteogenic differentiation 
of mesenchymal stem cells is addition with dexamethasone 
(Dex), ascorbic acid (Asc) and β-glycerophosphate (β-Gly). 
Osteogenic differentiation protocols using these three chemicals 
are frequently used for many experimental studies, including 
tissue engineering or detection of differentiation capabilities of 
particular cell types. These complex chemical mechanisms 
involved in osteogenic differentiation of stem cell cultures under 
the influence of Dex, Asc and β-Gly. Dex, Asc and β-Gly 
orchestrate several regulatory mechanisms during the 
differentiation process and does not start with an initial 
differentiation that if any insufficient. In some reports, Dex 
prevents apoptosis of BMSCs in confluent cultures (Song et al., 
2009) and promotes mesenchymal stem cell proliferation (Wang 
et al., 2012). In osteogenic differentiation, Dexamethasone acts 
as a key molecule to differentiate into osteogenic lineage. FHL2 
signaling is a critical signal in the osteogenic differentiation of 
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BMSCs and that Dexamethasone induces osteogenesis through 
the upregulation of FHL2 expression (Hamidouche et al., 2008). 
Then FHL2 induces the upregulation of the key transcription 
factor Runx2. Furthermore, Dexamethasone induces 
upregulation of TAZ, which binds to Runx2 (Hong et al., 2009). 
Additionally, Dexamethasone further induces osteogenic 
differentiation is the modulation of Runx2 phosphorylation 
through MKP-1 (Langenbach and Handschel, 2013). Ascorbic 
acid facilitates osteogenic differentiation by increasing the 
secretion of Collagen type I, as the binding increases integrin α
2β1 to Col1 (Kishimoto et al., 2013). This signal pathway 
increased phosphorylation of ERK1/2 in the MAPK signaling 
pathway and then PERK1/2 moved into the nucleus, where it 
binds to Runx2 and increase the osteogenic related lower signals 
then make expression of osteogenic proteins (Chaudhary and 
Avioli, 2000). β-Glycerophosphate increases osteogenic 
differentiation by the phosphorylation of ERK1/2 (Langenbach 
and Handschel, 2013). 
 
The objective of this study is to harvest a large amount 
of reliable sox9 positive cells as a new biomaterial in chicken 
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bone marrow. In chapters 3-6, the different culture conditions 
and insertion of growth factors (bFGF) were optimized for 
promoting and scale-up of cell proliferation and different cellular 
activities of isolated cells to tissue culture plate. By using these 
optimized culture media, the effects of on the cell expansion and 
their utility potential value of chicken bone marrow-derived 
sox9 positive cells were examined. Finally, in chapter 7, a study 
was conducted on the use of regenerative medicine using cellular 
secretions factors. The application of cellular secretions was 
considered to overcome the shortcomings of using cells directly 
like genome effect from different animals. I provide a clue about 
the possibility as a regenerative medicine using sox9 positive 
cell secretion bioactive substance to enhance bone regeneration. 
Given these observations, I provide establishment of a condition 
about the optimized culture environment of chicken sox9 positive 
cells for the feasibility of large-scale expansion and suggests 
about the possibility as a regenerative medicine. And I emphasize 
a necessity of more advanced research studies about identifying 
the soluble factors from cell secretion and how it could be a 
newly alternative medicines. And it brings advances in therapy 














1. Chicken as an experimental animal 
 
In recent years, chicken has been used as experimental 
animal models in pharmaceutical and medical studies and also in 
the pharmaceutical immunotherapy field due to its advantages 
such as short reproduction time, simple management, and high 
productivity in the egg (Farzaneh et al., 2017; Sudjarwo et al., 
2017). Especially, Chicken embryos are a significant useful 
historical research model in development sciences. However, in 
experiments with chickens, the lack of unusual markers like 
chicken specific antibodies can be seen as a disadvantage. There 
are many advantages to using eggs in developmental biology 
research. As an experimental animal, chicken egg have the 
advantage of being easy to access and easy to manipulation 
(Cloney and Franz-Odendaal, 2015). In the case of cell line 
derived from eggs and chicken embryos, it is used in a variety of 
therapeutic areas, including the production of vaccines. The line 
of cells derived by birds is an alternative to the production of 
viruses. Because using eggs are simple, flexible system that can 
be controlled with the ability to produce relatively easy and rapid 
vaccines. Recently, research is being done on the production of 
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transgenic animals using chickens, and pharmaceutical industries 
are developing in the field of medical research and research using 
transgenic animals. 
 
2. Difference in developmental stages between aves 
and mammals 
 
The avian species like chickens, quails and pheasants 
have unique characteristics based on their evolutionary position 
between mammals and other species. Development stage is the 
most significant difference from mammals performing 
organogenic reproduction in the body, and relevant or additional 
differences are found in the process of embryonic production. 
Unlike mammals, physiological polyspermy is usually induced at 
the time of fertilization, and numerous sperm are visible 
regardless of the formation of embryonic nuclei. Consequently, 
asymmetric cleavage yielding pre-blastodermal cells is 
observed throughout early embryogenesis and three stages of 
egg shell formation are placed before laying. According to the 
developmental stage, eggs from 1 to 3,000 cells form the soft 
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yellow eggshell of stage 1. The second stage of the egg, which 
consists of 3,000 to 30,000 cells, has a flexible egg shell that is 
light yellow, and the third stage, which consists of 30,000 to 
60,000 cells, is white eggshell. These differences with mammals 
can lead to unique cell fate decisions in various systems that can 
be prominent in the tissues and organs. 
 
3. Bone formation 
 
Two different processes involve the formation of the 
bones such as endochondral and intramembraneous ossifications 
play a pivotal role in inducing bone morphogenesis then 
differentiated into osteoblasts and chondrocytes (Shapiro, 2008; 
Zhang et al., 2011a). Endochondral ossification is responsible for 
the formation of the long bones such as the femurs and tibia. 
Cartilage tissue is formed prior to ossification, and subsequent 
ossification acquires the activities of rudimentary long bone 
formation, extension of its length and natural healing against 
various damages. Intramembranous ossification induces bone 
formation without cartilage development. In both process, bone 
formation is completed before birth, while the extension of bone 
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length continues until puberty. In mammals, endochondral 
ossification was completed until the birth and primitive cells for 
ossification usually disappeared in neonatal offsprings. The long 
bones are the source of bone marrow cells, of which 
endochondral ossification following hypertrophic proliferation 
and calcium deposition occurs. 
 
4. Stem cells 
 
First stem cells using study conducted more than 140 
years ago, and since 1868 stem cells have appeared in scientific 
literature in the works of famous German biologist Ernst Hatchell 
(Haeckel, 1879). From this start, many scientists tried to 
understand how these cells became different organs and tissues 
in the body (Becker et al., 1963; Ramalho-Santos and 
Willenbring, 2007). The culture of mouse embryonic stem cells 
was first reported by Evans and Kaufman in 1981. 
 
In fertilized embryo at the blastocyst stage (BL), 
embryonic stem cells exist in the inner cell mass and are an 
attractive therapeutic cell type due to their pluripotency 
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(Thomson et al., 1998). These embryonic stem cells (ES) have 
the unlimited self-renewal ability and differentiated into multi 
lineage adult type cells. Stem cells provide an infinite supply of 
cells that development part or all of the body's tissue, and this 
type of stem cell is called a pluripotent stem cell. They have the 
ability to sustain themselves throughout life. (Barry and Murphy, 
2004). Current study using stem cells is based on the facilitate 
the differentiation of stem cells into the required lineage and 
introduction of a form to replace or improve the functioning for 
the treatment disease (Odorico et al., 2001; Daadi and Steinberg, 
2009; Pal, 2009). For example, in vitro studies using ES cells 
can sustain indefinitely without differentiation, but can be divided 
into wanted cell types when providing appropriate environment 
or chemicals. (Thomson et al., 1998; Amit et al., 2000; Daadi and 
Steinberg, 2009; Lu et al., 2009; Pal, 2009).  
 
5. Bone marrow cells 
 
Bone marrow tissue consists of a variety of cells and 
been employed for stem cell engineering and clinical therapy 
(Haynesworth et al., 1992; Krebsbach et al., 1999; Bai et al., 
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2012; Bai et al., 2013). Bone marrow cells of different types have 
been established to date (Bianco et al., 2001; Jiang et al., 2002; 
Schwartz et al., 2002) and in the chicken, somatic chimeras have 
been derived from the transplantation of bone marrow cells into 
recipient developing eggs (Heo et al., 2011; Heo et al., 2012). 
An attempt to produce germline chimera and induce transgenesis 
has progressed rapidly in this species (Han et al., 2002; Han, 
2009; Han et al., 2015). Bone marrow is spongy tissue and 
consists multi different types of population like single nucleus 
cells that include monocytes, lymphocytes, stem related cells and 
progenitor cells (Alvarez-Viejo et al., 2013). Bone marrow 
derived single nuclear cells are very valuable for tissue 
engineering, such as genetic and regenerative disease studies. 
(Henrich et al., 2015b, a). Bone marrow is the soft and flexible 
tissue that found in the interior of hollow spaces of bones. Bone 
marrow is consists of red and yellow marrow that depending on 
the predominance of hematopoietic or fatty tissue(Malkiewicz 
and Dziedzic, 2012). Red marrow is also known as hematopoietic 
cells are produces red blood cells, white blood cells and platelets. 
Hematopoietic cells mature and migrate into sinusoids to enter 
the circulation when they are formed(Lang et al., 1992). 
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According to ages, red bone marrow is found on the flat bones 
such as the pelvic girdle and the sternum in adult stage. But in 
children, it is found in the medullary cavity of the long bones, 
such as the femur (Moore and Dawson, 1990; Gurevitch et al., 
2009). Yellow marrow is also known as stromal cells are 
produces fat, cartilage and bone (Zakaria and Shafrir, 1967; 
Gurevitch et al., 2007). Almost all of bone marrow is yellow bone 
marrow by the time a getting old age. Its main function is to store 
adipocytes that can serve as a source for energy (Tavassoli et 
al., 1977; Ortiz-Nieto et al., 2010). Bone marrow constitute multi 
cell types that include fibroblasts, macrophages, which contribute 
especially to red blood cell production, as they deliver iron for 
hemoglobin production, fat cells, osteoblasts, osteoclasts, 
endothelial cells, which form the sinusoids(Yin and Li, 2006; 
Mansour et al., 2012; Gordon et al., 2014). These derive from 
endothelial stem cells, which are also present in the bone marrow. 
 
Mesenchyme is embryonic connective tissue that is 
derived from the mesoderm and that differentiates into 
hematopoietic and connective tissue, whereas MSCs do not 
differentiate into hematopoietic cells(Phinney and Prockop, 
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2007). Mesenchymal stem cells are multipotent stem cells that 
have various differentiation ability into multi-lineage(Pittenger 
et al., 1999) such as including osteoblasts(Heino and Hentunen, 
2008), adipocytes, chondrocytes(Mackay et al., 1998), 
myocytes(Xie et al., 2006). Also it can be isolated using 
detection of cell surface marker. Mesenchymal stem cells are 
expressed CD44, CD73, CD90, CD105, while do not express 
CD11b, CD14, CD19, CD34 and CD45 surface marker(Kern et al., 
2006; Jin et al., 2013). 
  
Stem cells can be divided into two types according to 
their ability to differentiate. Pluripotent stem cells can generate 
every cell type of the organism (Verfaillie, 2009). Whereas 
multipotent stem cells are restricted to differentiated into more 
than one cell type. Mesenchymal stem cells has ability of 
mesodermal differentiation capacity that can generate cartilage, 
bone, adipocytes and fibrous connective tissue (Pittenger et al., 
1999). Also mesenchymal stem cells give rise to a hierarchy of 
cell population within the bone. In bone, it can be divided into a 
several development stages including mesenchymal stem cells 
like osteoprogenitor cell, preosteoblast, osteoblast and 
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osteocytes (Hofstetter et al., 1991; Aubin, 2001).  
 
Mesenchymal stem cells (MSCs) are type of adult stem 
cells and isolation and culture method is easy in in vitro culture. 
MSCs are have great plasticity and it can be great therapeutic 
tool (Camassola et al., 2012). MSCs are mainly found in bone 
marrow and also other specific tissue like amniotic fluide, cord 
blood, chorion and placenta tissue (Asgari et al., 2015; Gonzalez 
et al., 2015; Zhu et al., 2015). Mesenchymal-derived, 
multipotent cells have become a valuable resource for cell-to-
tissue regeneration and experimental modelling for 
differentiation and reprogramming(Anbari et al., 2014). Also, 
these cells are crucial to the development of novel 
biotechnologies for stem cells. From the various characteristics 
of bone marrow cells are considered as the basic material for 
clinical application to injuries and degenerative 
diseases(Krebsbach et al., 1999). For clinical implementation of 
bone marrow cells, their stable maintenance is important for 
optimizing manipulation protocol of chicken bone marrow cells 
and the large-scale expanded culture system has been used to 
high reproducibility of bone marrow cells. 
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5.1. Chicken cell culture medium 
 
Several culture systems have been developed for 
effectively maintaining chicken bone marrow cells. In most 
chicken bone marrow cell culture systems, Low doses of glucose 
have been employed (Khatri et al., 2009; Bai et al., 2013). 
Responding to recent demand on optimizing stem cell 
manipulation system, the establishment of a standard culture 
system and the development of simplified, optimized medium 
have become a part of major research objectives. Basically 
Dulbecco’s modified Eagle’s medium (DMEM) is in general use 
of supporting the growth of chicken stem cells, but its high 
osmolarity may have an adverse effect in the middle of cultivation 
on the cells (van de Lavoir et al., 2006). In chicken stem cell 
culture, Knockout Dulbecco’s modified Eagle’s medium 
(Knockout DMEM or KO/DMEM) is a basic culture medium which 
can support the growth ability in vitro. Although DMEM based 
culture medium can support the growth of various type of stem 
cells, the composition of KO/DMEM is suitable for all kinds of 
mammalian and non-mammalian stem cells and optimized culture 
environment of their growth rate (van de Lavoir and Mather-
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Love 2006; Amit and Itskovitz-Eldor 2016). Traditionally, the 
presence of fetal bovine serum (FBS) in KO/DMEM has been 
commonly used in cell proliferation due to the presence of growth 
factors. The fetal bovine serum routinely used for mouse 
embryonic stem cell culture may not be optimized for chicken 
cell culture environment; because of the fetal environment from 
which the FBS is derived is rich in growth factors (Horiuchi et al. 
2006). One of the fundamental problems with using FBS or 
chicken serum is that they are both very complex because they 
contain unknown compounds, including self-reproduction and 
differentiation factors. (Skottman and Hovatta 2006). 
 
Knowing the response of isolated bone marrow cells to 
addition of growth factors like bFGF and LIF will directly 
contribute to developing a culture system. It improves the 
efficiency of isolated cells culture system. Leukemia inhibitory 
factors is generally addition on culture medium and it typically 
reduce spontaneous differentiation. In mouse embryonic stem 
cells, it was discovered that in vitro propagation required the 
activity of the cytokine leukemia inhibitory factor (LIF) (Smith 
et al., 1988; Williams et al., 1988), and also it activates the Janus 
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kinase-signal transducer and activator of transcription (JAK-
STAT) signaling pathway (Boeuf et al., 1997). Fibroblast growth 
factors (FGFs) regulate developmental pathways like mesoderm 
patterning in embryo development stage through to the organ 
systems (Nutt et al., 2001; Deimling and Drysdale, 2011). The 
major function of FGF signaling in bone, FGF2, FGF9 and FGF18 
transcripts are found in differentiating osteoblasts during bone 
development and in the long bones (Ohbayashi et al., 2002). The 
FGF1 and FGF2 are expressed in mesenchymal cells prior 
accumulation of bone matrix at long bone development. FGFR3 
are found in preosteoblasts and osteoblasts. FGF2 signaling is 
important for development of bone. Overexpressed FGF2 causes 
abnormal bone development, but its inhibition caused to 
malformation of bones (Iseki et al., 1997). Also FGF signaling 
regulate cell proliferation and osteoblast precursor cells 
replication into osteoblasts and controlled apoptosis of immature 
osteoblasts (Mansukhani et al., 2000). Activation of FGF 
signaling can regulate genes involved at full steps of 
osteogenesis. 
 
5.2. Culture conditions of osteogenic differentiation 
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The standard procedure for the osteogenic differentiation 
of mesenchymal stem cells is addition with dexamethasone 
(Dex), ascorbic acid (Asc) and β-glycerophosphate (β-Gly). 
Osteogenic differentiation protocols using these three chemicals 
are frequently used for many experimental studies, including 
tissue engineering or detection of differentiation capabilities of 
particular cell types. These complex chemical mechanisms 
involved in osteogenic differentiation of stem cell cultures under 
the influence of Dex, Asc and β-Gly. Dex, Asc and β-Gly 
orchestrate several regulatory mechanisms during the 
differentiation process and does not start with an initial 
differentiation that if any insufficient. In some reports, Dex 
prevents apoptosis of BMSCs in confluent cultures (Song et al., 
2009) and promotes mesenchymal stem cell proliferation (Wang 
et al., 2012). In osteogenic differentiation, Dexamethasone acts 
as a key molecule to differentiate into osteogenic lineage. FHL2 
signaling is a critical signal in the osteogenic differentiation of 
BMSCs and that Dexamethasone induces osteogenesis through 
the upregulation of FHL2 expression (Hamidouche et al., 2008). 
Then FHL2 induces the upregulation of the key transcription 
factor Runx2. Furthermore, Dexamethasone induces 
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upregulation of TAZ, which binds to Runx2 (Hong et al., 2009). 
Additionally, Dexamethasone further induces osteogenic 
differentiation is the modulation of Runx2 phosphorylation 
through MKP-1 (Langenbach and Handschel, 2013). Ascorbic 
acid facilitates osteogenic differentiation by increasing the 
secretion of Collagen type I, as the binding increases integrin α
2β1 to Col1 (Kishimoto et al., 2013). This signal pathway 
increased phosphorylation of ERK1/2 in the MAPK signaling 
pathway and then PERK1/2 moved into the nucleus, where it 
binds to Runx2 and increase the osteogenic related lower signals 
then make expression of osteogenic proteins (Chaudhary and 
Avioli, 2000). β-Glycerophosphate increases osteogenic 
differentiation by the phosphorylation of ERK1/2 (Langenbach 
and Handschel, 2013). 
 
5.3. Characterization of Bone marrow-derived cells  
 
 As described above, mesenchymal stem cells were 
mononuclear cells with different capacities that could be 
separated from bone marrow. However, the biological 
characteristics of cells either do not meet all of the permitted 
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criteria and lack for typical stem cell activity. The isolation of 
uniform cell populations will help with treatment using MSC for 
specific tissue repairs. Bone marrow derived stem cells are 
clearly defined and stated criteria. Human MSCs must express 
CD105, CD73 and CD90 and not CD34, CD45, HLADR, CD14 or 
CD11b, CD19 or CD79α and be able to differentiate into 
osteoblasts, adipocytes and chondrocytes under standard in vitro 
differentiating conditions. Much of the current data, technique 
and tools are insufficient to characterize bone marrow cells as 
stem cells. More specific marker or method to isolate a 
homogenous population of marrow cells are required for 
classified as stem cells with accuracy.  
 
Progenitor cells have been described as cells that exist 
in gaps adjacent to mature and differentiated cells both in vivo 
and in vitro. Progenitor cells have been successfully isolated 
from several compartment, including fat tissue, synovium and 
bone marrow. Depending on the tissue source in which you are 
isolated, the progenitor cells has a distinct probability of 
differentiation and varies in frequency. There is evidence that 
there is uncommitted type of cells in culture derived from bone 
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marrow. Each cell in standby state was shown to represent a 
group of non-committed MSCs. After exposure to the fetal 
bovine serum, these same atmospheric cells generate a 
committed precursor to rapid growth and terminal differentiation. 
Within the stem cell hierarchy, several types of progenitor cells 
have been found to exist in bone marrow culture. Some research 
group have used non-staged cell replication to investigate the 
nature of committed programmers. The assessment of their 
differentiation showed that 30 % of fractions showed three germ 
layer differentiation potential and the other 70 % showed 
osteogenic and chondrogenic differentiation potential. There is a 
difference in our knowledge of stem cells that we need to fill in 
to make the most of their potential. We need to know more about 
the essential control of stem cells and what drives them to a 
particular differentiation path. The micro-environmental in 
which cells are commonly present affects these cellular 
properties. In medical field, many research conducted to adapt 
on application of stem cell or different type of progenitor cells. 
Because many specific tissues can be used to treat injuries and 
diseases. For example, chondroprogenitor cells can use on 
repairing articular lesions in articular cartilage. 
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6. Sox9 positive cells 
 
Chicken bone marrow cells are comprised of population may 
contain various undifferentiated progenitors and precursors, 
which could provide enormous information on cell differentiation 
using an ex vivo system.(Friedenstein et al., 1987; Pittenger et 
al., 1999; Csaki et al., 2007; Hudson et al., 2011; Dai et al., 2014). 
Also bone marrow derived cells give rise to a hierarchy of cell 
population within the bone. In bone, it can be divided into a 
several development stages on osteochondro progenitor cells 
like mesenchymal stem cells. Osteochondro progenitor cell, 
preosteoblast, osteoblast, osteocytes, chondrocyte, proliferate 
chondrocyte and hypertrophic chondrocyte (Hofstetter et al., 
1991; Aubin, 2001). Osteochondral progenitor cells have the 
ability to become osteoblasts or chondroblasts. Osteochondral 
progenitor cells are located in the inner layer of the 
perichondrium, the inner layer of the periosteum, and in the 
endosteum. From these locations, they can be a potential source 
of new osteoblasts or chondroblasts. Also it can be differentiated 
into osteoblastic, chondroblast lineages (Friedenstein et al., 1966; 
Orlic et al., 2001; Toma et al., 2002; Morikawa et al., 2009). 
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Osteochondro progenitor cells are very important for making a 
bone and cartilage. They can be found inner of the long bone and 
can be differentiated into osteoblast and chondrocyte.  
A more homogeneous osteogenic and chondrogenic 
progenitor cells may be necessary to treat bone or cartilage more 
effectively. The differentiation of chemical cells into 
chondrocytes and their associated accumulation in the ECM are 
carefully controlled by the Paracrine factor. 
 
Sox9 as a transcriptional mediator, transforming growth 
factor beta (TGF-β) and bone morphogenetic protein (BMP) 
signalling are responsible for initiating expression of 
cartilaginous ECM such as aggrecan, collagen types II and XI, 
fibronectin and tenascin as shown in in vitro murine micro mass 
cultures (Chimal-Monroy and Diaz de Leon, 1999; Hatakeyama 
et al., 2004). The chondrogenic differentiation of the cells in vitro 
through TGF-β1 is mediated by both Smad3 and Wnt-
associated β-catenin (Church et al., 2002). In clinical 
applications, ideal cell sources are easily isolated, plentiful, and 
can pose minimal risk to patients. In cartilage regeneration, there 
are special features needed to produce a viable and durable 
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cartilage. These features include the dominance of collagen type 
II, and the binding of subcutaneous plates and surrounding 
cartilage. Mature articular cartilage develops from the embryonic 
mesodermal precursors and is differentiated into 
chondroprogenitogers and finally differentiated into mature adult 
chondrocytes or synoviocs. There is a hypothesis that the 
progenitors holding in these adult joint tissues provides a 
potential reservoir for chondroprogenitors. The application of 
chondroprogenitors to treat and subsequently suppress the onset 
of disease is the focus of current research efforts. 
 
6.1. Characterization and Signal Pathway 
 
Multiple type of osteochondro progenitor cells marker is 
used for detection. Generally various gene and surface protein 
markers are expressed on the osteochondro progenitor cells. 
Sox9 is a transcription factor and regulate chondrocyte 
differentiation and regulates transcription of the anti-Mullrian 
hormone (AMH) gene (Garside et al., 2015). Sox9 is key 
regulator signal for the osteochondro progenitor cells undergo 
osteogenic and chondrogenic differentiation. The transcription 
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factor Sox9 can be involved and control many signal pathways 
and it is also found in osteochondro progenitor cells, suggesting 
that they are important in early signal pathways (Pan et al., 
2008). End of each signal pathways, osteoblasts make a bone and 
chondroblast make a cartilage. Runx2 also known as core-
binding factors subunit alpha-1 (CBF-alpha-1) and Osx (a zinc 
finger containing transcription factor) are necessary for 
osteochondro progenitor cells to differentiate into the osteoblast 
cell lineage (Chen et al., 2009; Shahi et al., 2017). Furthermore, 
Runx2 regulates the expression of major bone matrix genes on 
differentiation (Chung, 2004; Fujita et al., 2004). Runx2 is a 
factor of role in hypertrophic chondrocyte maturation. It is 
effected by Wnt/β-catenin signaling. β-catenin signal 
pathways are important role in cell fate determination. WNT/β-
catenin signaling-dependent Runx2 expression (Hill et al., 2005; 
Dong et al., 2006). In the presence of Wnt3a, an activator of the 
canonical WNT signaling pathway, β- catenin transport to the 
nucleus, where it binds TCF/LEF-1 and leads to the 
transcription of Runx2 (Komori, 2011; Voronkov and Krauss, 
2013). Through Sox9 as a transcriptional mediator, transforming 
growth factor beta (TGF-β) and bone morphogenetic protein 
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(BMP) signaling are responsible for initiating expression of 
cartilaginous ECM such as aggrecan, collagen types II and XI, 
fibronectin and tenascin as shown in in vitro cultures 
(Hatakeyama et al., 2004; Chimal-Monroy and Diaz de Leon, 
1999). TGF-β is representative markers for cell proliferation 
and differentiation during bone and cartilage development stage 
(Sakaki-Yumoto et al., 2013). TGF-β signals relations with 
Sox9 and Runx2 signalling pathways and regulates cell lineages 
during endochondral ossification development stage (Yang et al., 
2001; Chen et al., 2012). TGF-β signal stimulates 
differentiation potential into chondrocytes and osteoblasts with 
multiple signals like FGF, Msx1, and Ctgf signalling pathways 
(Guo and Wang, 2009; Parada et al., 2013). Alkaline phosphatase 
(ALP) is the early expressed functional genes in the process of 
calcification and cartilage formation (Amano et al., 2009). It is  
expressed early development stages and decreased in later 
development. The regulatory signaling pathways are controlling 
osteogenic and chondrogenic differentiations. And ALP 
expression are controlled with WNT/beta-catenin, BMP, Runx2 
signaling cascades. Collagen type I is most abundant extracellular 
matrix component and is marker of the end product like bone and 
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tendons (Liu et al., 1995). Fully differentiated cells reduction 
expression levels of collagen type I and II and an increase of 
collagen type X and Aggrecan (Aigner et al., 1995; Haaijman et 
al., 1997). 
 
7. Extracellular matrix and cell-to-cell interaction  
 
The ECM plays an important role in regulating the 
biological characteristics of the growth factors and the cytokine. 
Growth factors can be isolated and inhibited from binding into the 
receptor, or the ECM can directly affect the growth factor 
receptor (Hildebrand et al., 1994; Santra et al., 2002). In addition 
to receiving signals from the ECM, cells recite by releasing 
enzymes and ECM components within the ECM that produce 
protein for growth factors. ECM is influenced by hierarchical 
structures and is adapted to the functions of specific tissue or 
cell types. ECM components perform prominent functions only 
after relying on the network in which the tissues or tissues are 
assembled in turn, or on structural elements of insoluble, such as 
fiber or microstructure. These interactions represent the give-
and-take relationships that define the behavior of cells 
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(Behonick and Werb, 2003). ECM have physical functions as well 
as biochemical functions; they are bound polymeric bonds that 
form tissue and form tissue. The ECM appears in many different 
forms because it is present in a wide variety of tissues (Knudsen, 
2003). Since the cell itself produces the biochemical, surface 
interactions are likely to be associated with the cell and typically 
work as needed by specific tissues and networks (Dityatev et al., 
2010). The ECM is an important substrate for cellular 
communication and is suitable for providing signal molecules to 
guide cells.  
 
The components of the ECM include a fiber protein such 
as collagen and elastin, glycoproteins such as fibronetin and 
tenasin (Faissner et al., 1994; Bandtlow and Zimmermann, 2000). 
GAG consists of a long unit of disaccharide composition which is 
the disaccharide formulation that distinguishes between 
chondroitin sulfate (CS), heparan sulfate (HS), keratin sulfate 
(KS), dermatan sulfate (DS) and hyaluronan (HA). The unique 
composition of the disaccharides makes GAGs truly information 
dense biological molecules (Turnbull et al., 2001). Because of 
their molecular structure, GAG is suitable for combining many 
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different signal molecules. Hyaluronic acid (HA) is an exception 
because it is not a protein binding, it is not self-supplied and 
consists of the same breakdown enzyme unit (Toole, 2001). HA 
is synchronized to the plasma membrane and forms the backbone 
of the cartilage ECM. Most GAG are shared in key proteins. It is 
called a proteoglycan. According to a recent study, cells are 
surrounded by peri-cellular matrix that contain proteoglycan and 
thin collagen filaments without direct contact with the 
surrounding substrate (Hunziker et al., 1997). It is well 
established that ECM components play an important role in the 
differentiation of hematopoietic stem cells (Drzeniek et al., 1997). 
However, although little is known about the effect the ECM has 
on MSC differentiation, some studies show that ECM also plays 
an important role in MSC differentiation (Xu et al., 1998; Corsi 




 The fact that HA has many physiological features has 
drawn great attention over the past few decades. It was initially 
assumed that the HAs function was based on physical 
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characteristics such as joint lubrication, tissue homeostasis, and 
tissue adhesion. However, it is also a major regulator for cell 
behavior during such processes as embryogenesis, reproduction, 
morphogenesis, migration, proliferation and differentiation (Chen 
et al., 2006; Solis et al., 2012). HA has also been used clinically 
as a medical product and has become an important component in 
creating new biomaterials that are useful in tissue engineering 
and regenerative medicine (Allison and Grande-Allen, 2006; 
Serban and Prestwich, 2008; Burdick and Prestwich, 2011; 
Prestwich, 2011). As a pain relief treatment, HA is injected into 
bone or cartilage disease patient joints. The injection is not only 
to relieve pain and replace insufficient fluids but also such as the 
stimulation of chondrocyte growth, facilitate cell destruction and 
the production of cartilage (Goldberg and Buckwalter., 2005). 
 
7.2. Chondroitin Sulfate 
 
 CS is a key component of the ECM and is critical to 
maintaining the structural integrity of the organization (Wu et al., 
2010a). CS has useful biological properties used in cartilage 
engineering. These traits include anti-inflammatory activities, 
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water and nutrient absorption, wound therapy, and cellular 
activity that will help restore arthritis joint function (Pipitone, 
1991; Ronca et al., 1998; Li et al., 2004). Effect of CS on 
chondrocyte culture improved produce cartilage specific matrix 
and sustaining of cellular activity (Sechriest et al., 2000). Some 
results show modulatory effect of extracellular CS on 
chondrocytes and a stimulatory effect of CS on proteoglycan and 
GAG production in cartilage ECM has also been shown (Huang, 
1974; Huskisson, 2008). Importantly, CS is highly expressed 
during the chondrogenic progenitor cells condensation of MSCs, 
suggesting its importance in chondrogenesis (Barry et al., 2001; 
Kamiya et al., 2006). Another study showed CS increased 
chondrogenesis while down regulation of osteogenic related gene 
and cell proliferatio(Uygun et al., 2009). This positive impact of 
CS on bone marrow derived stem cell becomes an interesting 
molecule that tests its impact on directly from the marrow. 
 
7.3. ECM and the Stem Cell Niche 
  
The term “ niche ”  was first described in 1978 
(Schofield et al., 1978). Research into cell biology has emerged 
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in relation to the discovery of niche, focused on the micro-
environmental support of stem cells. Stem cell niche include 
surrounding cell components associated signals from these 
supporting cells (Li and Xie, 2005). A niche requires a balanced 
environment that determines the fate of cells between self-
renewal and differentiation. Without a balanced environment, 
improper differentiation occurs (Solis et al., 2012). Niches is a 
specific anatomical location that regulates how stem cells 
participate in repair, regeneration, and maintenance (Scadden, 
2006). According to a recent study analyzing stem cell gaps, cell 
types such as enthelial cells, osteo and chondro related cells and 
bone marrow derived stem cells are essential to building 
functions. The pressure on the metabolic activity of stem cells 
may require special support compared to other cells in the body. 
Feedback control is typically given to stem cell pools because 
they are expandable and collapsible and can sometimes suffer 
large probability variations under certain assumptions (Lam et 
al., 2006; Morrison and Spradling, 2008; Vazin and Schaffer, 
2010). The use of ECM molecules while separating them from 
bone marrow may provide a biomimicry environment in which 
can receive signals, as in vivo joints. This may lead to the 
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production of more stable target tissue for use in the 
regeneration of the degraded tissue in turn. 
 
8. Conditioned media 
 
Over the past few years, many study groups have studied 
using conditioned media to evaluate efficiency as a generative 
biomarker. Released protein from conditioned media by cultured 
cells is a rich source of materials for biomarker as an application 
of novel treatment (Xue et al., 2008). Useful proteins released 
from cells culture medium can be used as novel bio-active 
substances to apply for the disease or regenerative treatment 
effects. This technique provides a useful, easy and effective 
method for discovering new biomarkers. The point here is that 
protein analysis is enhanced due to finding identification of 
biomarker candidate in which grown serum-free culture 
conditions (Righetti et al., 2003). Protein found in the medium 
controlled by the cell lines will come from cells through many 
different channels.  
 
The development of mass spectroscopy (MS), unlabeled 
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techniques, LC systems, and biometrics approaches had a 
profound impact on protein dynamics (Wong et al., 2009). These 
advances, combined with analysis of conditioned media, will 
undoubtedly facilitate identification of candidate biomarkers in 
cell culture environments. 
 
9. Future directions, Perspective 
 
Bone marrow-derived, multipotent cells are crucial to 
the development of novel biotechnologies for cell therapy. And 
also it become a valuable resource for cell-to-cell tissue 
regeneration and experimental modelling for differentiation and 
reprogramming(Wagers and Weissman, 2004). Bone marrow 
cells are considered as the basic material for clinical application 
to injuries and degenerative diseases(Lu et al., 1996). For 
clinical implementation of bone marrow cells, their stable 
maintenance is important for optimizing manipulation protocols 
and the large-scale expanded culture system has been used to 
high reproducibility of bone marrow cells. 
 





Stem cell therapy majorly targets autologous and 
allogenic cell transplantation into patients by local transplantation 
or systemic infusion. Regarding bone-derived, cell therapy, 
mesenchymal stem cells may be available for various clinical 
applications, which has been continuously studied in regards to 
stem cell transplantation and autoimmunity (Daikeler and Tyndall, 
2007; LoCascio et al., 2011; Alexander et al., 2013). 
Mesenchymal stem cells have low levels of major 
histocompatibility complex (MHC) class I antigens and do not 
express MHC class II and other stimulatory molecules (Koch et 
al., 2015). However, different expression pattern is detected, 
which is influenced by cell type and the cell characteristics and 
culture condition may effect on mesenchymal stem cells 
immunogenicity. Based on stem cells characteristic, 
immunosuppressive properties of transformed (differentiated) 
cells can be imaged as a potential risk (Flores-Figueroa et al., 
2006; Merino-Gonzalez et al., 2016).  
 
This multiple range of adaptable characteristics are 
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increasing uses of mesenchymal stem cells in tissue regenerative 
field (Caplan, 2007). But differentiation character into unwanted 
lineage and immunosuppressive have potential risks of use of 
mesenchymal stem cells. Differentiation into unwanted lineage 
means cell transformation of MSCs that can occur in long time 
cell culture. And immunosuppressive properties mean 
development into tumor. So for answering to the risk and 
question in using mesenchymal stem cells in regenerative 
therapeutic field, must be prepare and make according to good 
manufacturing practices (GMP), standard operating procedures 
(SOP) to obtain efficient and safe cell therapy. 
 
9.2. Use of chicken bone marrow-derived progenitor cells 
in regenerative medicine 
 
Bone marrow derived stem cells can differentiate into 
specific target cell type. The bone formation related cells 
develop into bone and cartilage related cells and then accumulate 
in the outer layer of the bone during intramembranous and 
endochondral ossification (Shapiro, 2008). In current clinical 
treatments, bone marrow derived mesenchymal stem cells are 
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used directly for cartilage regeneration. (Jin et al., 2007).  
 
In order to develop cell transplantation technology, the 
retrieved target progenitor cells and optimization of culture 
environment and techniques are necessary. Advanced 
regenerative medicine currently uses in implantation system. 
The current trend leads to short-term recovery of bone and 
cartilage disease related symptoms using cells to prevent 















Experimental animals and collection of bone marrow cells. 
 
4-day-old White leghorn(WL) being maintained at the 
University Animal Farm, Seoul National University were 
employed as laying hens and either hatched or 4-day-old chicks 
were euthanized for retrieving bone marrow cells by our 
standard protocols. All procedures of herd management and 
experimental protocols were approved by the Institutional 
Animal Care and Use Committee (IACUC) of Seoul National 
University (SNU 140912-4). 
 
Culture of bone marrow-derived cells 
 
One million bone marrow cells were spread into a 100-mm tissue 
culture dish and subsequently cultured in high glucose DMEM 
(Gibco Invitogen) supplemented with 10% (v/v) FBS at 37℃, 5% 
CO2 in a humidified air atmosphere. On day 3 of culture, 
erythrocytes and non-adherent cells were removed and the 
medium was changed every three days’ intervals. When bone 
marrow-derived cells reached to 80% confluence (at the end of 
P0), the cultured cells were dispersed with 0.25% trypsin-
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EDTA (Gibco Invitogen). After total cell number was counted by 
hemocytometer, the cells were replated into the dish for 
subculture. At the end of each passage, morphology of the cells 
cultured in the dishes was observed under an inverted 
microscope (TS 100-F, Nikon, Tokyo, Japan). 
 
Assessing of cell proliferation during in vitro-culture of 
cells 
 
Cell number was monitored at the end of each passage up to 12 
passages. Both the cell number accumulated from primary 
passage and actual cell number proliferated at each passage were 
counted. Calculation of actual cell number was the subtraction of 
the cell number counted at the end of passage from that counted 
at its prior passage. 
 
Colony forming unit fibroblast (CFU-F) assay 
 
To quantify cell proliferation, CFU-F assay was conducted. One 
million cells were seeded on a 100 mm culture plate, and the 
medium was changed at interval of 3 days. On day 14 of culture, 
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some were stained with crystal violet and others were 
subcultured continuously and the colonies of more than 55 cells 
were provided for measuring cell size. 
 
Analysis of the relative mRNA levels using real-time PCR 
 
The bone marrow cells were transferred into RNAlater, 
and subsequently stored at -80℃ until qRT-PCR analysis. 
Total RNA from chicken bone marrow cells was extracted using 
RNeasyTM Mini Kit and cDNAs were synthesized from the total 
RNA using the M-MLV reverse transcriptase. The expression 
of specific chicken bone marrow cells genes was quantified by 
real-time PCR using iQTM SYBRⓇ Green Supermix. The beta-
actin primer was included in every treatment groups for 
standardization and the mRNA level of each gene was normalized 
to that of beta-actin. The total primer sequences are listed in 
Table 1. 
 
Induction of differentiation 
 
To confirm differentiation of chicken bone marrow cells in vitro, 
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ostogenic, adipogenic and chondrogenic differentiations in vitro 
were induced by standard protocols.  
 
Osteogenic differentiation 
Basic culture medium for osteogenesis was high glucose DMEM 
supplemented with 100 µM dexamethasone, 10mM ß-
glycerophosphate and 50 µM ascorbate-2-phosphate. At the 
end of culture for 3 weeks, the cells were fixed with cold 70% 




For adipogenic differentiation, high glucose DMEM supplemented 
with 0.5 mM isobutyl-methylxanthine, 200 µM indomethacin, 1 
µM dexamethasone and 10 ug/ml human insulin was used. The 
cells were cultured for 3 weeks and medium change was 
conducted every three days. After being fixed with 10% (v/v) 






Chondrogenic differentiation was monitored in 15-ml 
polypropylene centrifuge tubes to create 3-dimensional 
environment. DMEM supplemented with 10 ng/ml TGF- ß 1, 1x 
Insulin-Transferrin-Selenium, 10-7 M dexamethasone, 1.25 
mg/ml BSA, 50 µg/ml ascorbic acid, 5.33 µg/ml linoleic acid and 
40 µg/ml L-proline was employed for the chondrogenesis. At the 
end of the culture for differentiation (3 weeks), the pellets were 
embedded in paraffin block and Alcian blue and nuclear fast-red 




All experiments were replicated more than three times. A 
generalized linear model (PROC-GLM) created using Statistical 
Analysis System (SAS) software version 9.4 (SAS Inst. Inc., 
Cary, NC) was used to analyze the data. When a significant model 
effect was detected, comparisons among groups were 
subsequently conducted the Duncan methods. A p value of less 
than 0.05 determined as a significant difference. 
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Primer sequence Size 
(bp) 
Temp 
(℃) Sense (5’ >3’) Anti-sence (5’ >3’) 
β-actin JN639846.1 ATGAAGCCCAGAGCAAAAGA GGGGTGTTGAAGGTCTCAAA 223 60 
Pou V NM_001309372.1 TCAATGAGGCAGAGAACACG GGACTGGGCTTCACACATTT 154 54 
Nanog NM_001146142.1 CAGCAGACCTCTCCTTGACC TTCCTTGTCCCACTCTCACC 187 54 
Sox2 AB092842.1 AGGCTATGGGATGATGCAAG GTAGGTAGGCGATCCGTTCA 163 54 
CD31 XM_004946203 GAAGAAAGAGATGAGCAGGCAGGAC TGTAGCAAGGCAGATCGAGACA 204 60 
CD34 XM_015299049.1 GTGCCACAACATCAAAGACG GGAGCACATCCGTAGCAGGA 239 54 
CD44 NM_204860.2 CATCGTTGCTGCCCTCCT ACCGCTACACTCCACTCTTCAT 290 55 
CD45 NM_204417.2 CACTGGGAATCGAGAGGAAA CTGGTCTGGATGGCACTTTT 212 57 
CD105 NM_001080887.1 ACGGATGACACCATGGAAAT ATGAGGAAGGCTCCAAAGGT 217 57 
Sox9 AB012236.1 GCTTTCTCGCATGAATCTCC TTGGGGAAGGTGTTCTCTTG 174 57 
Runx2 NM_204128.1 CAGACCAGCAGCACTCCATA TTGGGCAAGTTTGGGTTTAG 154 54 
CoLIa2 NM_001079714.2 CAAACCAGGCGAAAGGGGTC AATGGACCACGGCTTCCAA 133 60 
CoLIIa1 NM_204426.1 AAGATGTTGTAGGACCCCGA CATCTGCGCCGCAAAGTTTC 212 60 
CoLXa1 XM_003641007.3 GGCCAATCCACAATCCCAGA CCCCAGGGTAGGCTTTTGAG 148 59 
Aggrecan NM_204955.2 AACCTTCAGCATCTGGAGCC GAGGAAGCCACTTTCTCC 154 59 








Characterization of Bone Marrow Cells 
Retrieved from Neonatal Chicks; 






 Bone marrow tissue consists of a variety of cells and has 
been employed for stem cell engineering and clinical therapy 
(Haynesworth et al., 1992; Krebsbach et al., 1999; Bai et al., 
2012; Bai et al., 2013). Bone marrow cells of different types have 
been established to date (Bianco et al., 2001; Jiang et al., 2002; 
Schwartz et al., 2002) and in the chicken, somatic chimeras have 
been derived from the transplantation of bone marrow cells into 
recipient developing eggs (Heo et al., 2011; Heo et al., 2012). 
An attempt to produce germline chimera and induce transgenesis 
has progressed rapidly in this species (Han et al., 2002; Han, 
2009; Han et al., 2015). 
 
Nevertheless, basic information on chicken bone marrow 
cells culture has not reported yet and a standard protocol of 
manipulation and cellular properties have not been established. 
Furthermore, the feasibility of the culture environment should be 
confirmed in chicken bone marrow cells for both preclinical 




Long bones, such as the femur, have been a major source 
of bone marrow cells in which endochondral ossification is 
responsible for bone formation (Reddi, 1981; Provot and Schipani, 
2005). In mammals, bone morphogenesis roughly completes until 
hatching and primordial cells of the bone marrow usually mature 
in neonatal offspring (Ortega et al., 2004; Mackie et al., 2008). 
It is hypothesized that bone formation in chickens differs from 
that in mammals considering their ex vivo development. The 
collection of bone marrow-derived progenitor cells could allow 
for the development of bone marrow-mediated biotechnologies 
for tissue regeneration (Salgado et al., 2004). 
 
This study was conducted to understand both the 
histology and cellular properties of bone marrow cells retrieved 
from 4-day-old neonatal chicks. Histology, cell culture 
outcomes, specific marker expression, and differentiation 
potential were evaluated to describe the academic and industrial 
feasibility of chick bone marrow cells as a new biomaterial. 
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In experiment 1, histological examination was conducted for the 
femurs collected from either hatched or 4-day-old chicks. In 
experiment 2, the bone marrow cells retrieved from 4-day-old 
chicks were subcultured and cell morphology and proliferation 
profile were monitored. As experimental parameters, both 
cumulative cell number from the time of seeding and actual cell 
number counted at the end of each subpassage were employed. 
In experiment 3, the reactivity of the P5 cells to the specific 
markers for osteochondrogenesis (Sox9, Col I, Col II and AP) 
and gene expression of the P0 and P5 cells were evaluated. The 
expression of specific genes for pluripotency (pouV, Nanog and 
Sox2), endothelial cell (CD31), hematopoietic cell (CD34 and 
CD45), mesenchymal stem cell (CD44), endoglin (CD105) and 
osteo-chondrogenesis (Sox9, Col I, Col II, Col X and Aggrecan) 
was subsequently monitored. In experiment 4, osteogenic, 




Histological examination of the femur  
 
The femurs were collected after euthanizing and subsequently 
rinsed with Dulbecco’s phosphate-buffered saline (DPBS; 
Welgene Inc., Daegu, Korea) supplemented with 1% (v/v) 
antibiotics and 2% (v/v) fetal bovine serum (FBS; Welgene Inc., 
Daegu, Korea). After muscles and other connective tissues were 
mechanically removed, the collected bones were fixed with 4% 
(v/v) paraformaldehyde. Then the fixed long bone tissue was 
decalcified in 15% (v/v) EDTA in order to soften the tissue. Then 
tissues were embedded in paraffin blocks, which were 
consequently dissected into the specimen of 6 µm in thickness. 





The bone marrow cells were washed with PBS, fixed with 4% 
(v/v) paraformaldehyde and subsequently permeabilized with 0.1% 
(v/v) of Triton X-100. After washing, the cells were blocked 
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with 10% (v/v) normal goat serum and treated with Sox9, 
Collagen type I, Collagen type II antibodies during overnight at 
4℃ and secondary antibody for 2 hours at room temperature. 
After 3 times washing step, stained with DAPI staining solution 
to enable nuclear visualization and images captured via 
fluorescent microscopy using software from NIS Elements, Inc. 
 
Alkaline phosphatase (AP) activity assay 
 
At Passage 5 cells were fixed with 4% (v/v) paraformaldehyde 
and then NBT/BCIP solution (Roche Applied Science, 
11681451001) treated in Buffer 3 (0.1 M Tris-HCl pH 9.5, 0.1 













A total of 110 chicks were euthanized for histological and 
cytological examinations. As shown in Figure 1, the bone marrow 
matrix consisted of a variety of cells, including 
osteochondrogenic cells and mature bone marrow cells such as 
osteoblasts, osteoclasts, chondrocytes, hypertrophic 
chondrocytes, hematoblasts, granular leukocytes, and 
erythrocytes. Numerous positive cells had spread into both the 
epiphyseal and diaphyseal regions, while the epiphyseal line was 
not distinct. There were no histological differences between 
hatched and 4-day-old chick femurs. Four distinct regions 
(zone of resting, zone of hypertrophy, zone of proliferation, and 
erosion zone) were visible. Proliferating chondrocytes began to 
transform into hypertrophic chondrocytes in the center of the 
bone matrix. 
 




As shown in Figure 2, culture of bone marrow cells resulted in a 
cuboidal cell-dominant population. At the time of seeding, cells 
of different types were visible, but cuboidal cells formed a 
colony-like structure and were continuously established up to 
the end of primary culture. Subculture of this cell population 
enabled dispersion of the cuboidal cells, and the process of 
subpassage was conducted when the cells reached 80% 
confluency. A significant (p<0.0001) model effect was detected 
in both parameters (cumulative and actual cell number) when the 
number at the end of each passage was compared (Figure 3). 
Vigorous proliferation was detected, which peaked at P2 and P3. 
The cumulative cell number plateaued between P6 and P7, but 
decreased proliferation activity was detected between P4 and P7. 
Compared with P2 and P3 cells showing the best proliferation, 
significantly (p<0.05) decreased activity was detected in P8 cells. 
 
Gene and marker expression of cultured bone marrow cells 
 
Reverse transcription polymerase chain reaction (RT-PCR) 
analysis revealed that the expression of Col X and Aggrecan was 
prominent in P0 cells. As shown in Figure 4, strong expression  
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Figure 1. Morphology of the femur retrieved from immediately 
after hatching (C) or 4-day-old chicks (A, B). (A) Four-day-
old chick. Epiphyseal line was not formed and the stromal tissue 
of the diaphysis and the epiphysis was mixed. Hematoxylin and 
eosin staining demonstrated numerous positive cells spreaded 
into both the epiphyseal and the diaphyseal regions. Bar=250 um. 
Four-day-old (B1-3) and hatched (C1-3) chicks, which 
observed low, middle and high maginifications. Bar=100, 50 and 
25 um, respectively. Bone matrix consisted of a variety of the 
cells that involved in endochondral ossification. Four distinct 
regions, zone of resting, zone of hypertrophy, zone of 
proliferation and erosion zone, were visible at low magnication, 
which consisted of osteogenic and mature bone marrow cells 
such osteoblast (ob), osteoclast (oc), chondrocyte (c), 
hypertrophic chondrocyte (hc), hematoblast (h), granular 

























Figure 2. Morphology of the bone marrow cells retrieved from 
4-day-old chicks. After being collected by enzymatic digestion, 
the cells were seeded onto a 100mm tissue culture dish and 
subsequently cultured in high glucose Dulbecco’s minimal 
essential medium (Welgene Inc., Daegu, Korea) supplemented 
with 10% (v/v) fetal bovine serum (Welgene Inc., Daegu, Korea). 
Morphology of the cells cultured were monitored at the end of 
the passage 0, 5 and 10. The cultured cells transformed into 
amorphous morphology of either cuboidal or stromal cell-















Figure 3. Proliferation of the bone marrow cells retrieved from 
4-day-old chicks. Retrieved cell number at the end of each 
passage up to the passage 10 (P10) was counted. (A) Cumulative 
number of the cells cultured from P0 and (B) Actual number of 
the cells retrieved from each subpassage. Significant (p<0.0001) 
model effect was detected in each parameters and vigorous 
proliferation was gradually decreased from passage 4. Compared 
with P2 and P3 showing the best proliferation, significant 
retardation of the cell activity was detected from P8. Data were 
indicated as Mean±SE and different script in each passage 










































of Col I, Sox9, Sox2, CD44, CD45, and CD105 was also detected. 
In contrast, Col II, PouV, Nanog, CD31, and CD34 were weakly 
expressed or not detected. In P5 cells, all genes related to 
osteochondrogenesis (Sox9, Aggrecan, Col I, Col II, and Col X) 
were expressed at P5, while the expression of Nanog and CD34 
was not detected. The expression of CD31, an endothelial cell 
marker, was also strong. Other genes were expressed similarly 
compared with P0 cells. 
 
Most P5 cells (82.2 ± 4.2% of the total population) were Sox9-
positive (Figure 5). Considerable expression of Col I (67.0 ± 6.2) 
was detected, which was higher than that of Col II (32.2 ± 6.4). 
However, Col I and Col II expression was much less than the 
reactivity to Sox9. Counterstaining of each marker with DAPI 
clearly demonstrated cell-specific expression. In the co-
expression of Sox9- and Col I-positive cells and of Col I and 
Col II was observed. As shown in Figure 6, AP activity was 
strongly positive in P5 cells. 
 
Figure 4. Expression of various genes in bone marrow-derived 
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cells collected from 4-day-old chicks. The cells collected at the 
end of passage 0 (A) and 5 (B) were provided for RT-PCR. The 
expression of specific genes for pluripotent cell (pouV, Nanog 
and Sox2), endothelial cell (CD31), hematopoietic cell (CD34 and 
CD45), mesenchymal stem cell (CD44) and endoglin (CD105) 
and osteo-chondrogenesis (Sox9, Col I, Col II, Col X and 
Aggrecan) was monitored. (A) Prominent expression of Col X 
and Aggrecan was detected, and the expression of Col I, Sox9, 
Sox2, CD44, CD45 and CD105 was also detected. Col II, PouV, 
Nanog, CD31 and CD34 expression was weakly or not detected. 
(B) All genes related osteo-chondrogenesis were expressed at 
P5, while expression of Nanog and CD34 was not detected. Other 
genes were concomitantly expressed with the genes related to 























Figure 5. Expression of specific marker proteins for osteo-
chondrogenesis. Expressions of Sox9 and Sox9-related, 
collagen type I (Col I, fibrous cartilage marker) and collagen type 
II (Col II, proliferative chondrocyte marker) proteins were 
monitored in the bone marrow of 4-day-old chick bone marrow 
cells. The cells were collected from passage 5 and provided for 
immunocytochemistry. (A) Expression of Sox9, Col I and Col II 
(A1-3), and their percentage of expression to total cultured 
cells (A4) were evaluated. Sox9 expression were significantly 
(p<0.05) dominant than the expression of Col I and Col II, and 
more than 80% of the cell cultured expressed the Sox9. Data 
were indicated as Mean±SE. (B) Immunofluorescence counter 
staining of Sox9, Col I or and Col II with DAPI. P5 bone marrow 
cells were provided for this analysis. Prominent expression of 
Sox9 (red color), Col I (red color) and Col II (green color) was 
detected with nuclear-specific DAPI straining (blue color), 
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Figure 6. Staining of bone marrow cells by alkaline phosphatase 
(AP), a hypertophic cartilage marker. Bone marrow cells 
collected from 4-day-old chicks were subcultured 5 times and 
were subsequently provided for AP staining. Observation of 
morphology before (A1, B1) and after (A2, B2) staining at low 
(Bar=250 um) and high (Bar=100 um) magnifications. Strong 
reactivity of AP was detected, which indicates ossification is 























Comparison of the multi-lineage differentiation potential of 
chicken bone marrow cells 
 
As shown in Figure 7, both osteogenic and chondrogenic 
differentiation were detected, while adipogenesis was not 
noticeable under this differentiation regime. After three weeks 
of osteogenic differentiation, P5 cells induced for osteogenesis 
exhibited strong Alizarin Red S staining. Alcian blue staining was 
also strongly detected following adipogenic differentiation. 





Figure 7. Differentiation of 4-day-old, chick bone marrow-
derived cells collected from passage 5. (A) Osteogenic 
differentiation. Total 3x105 cells were seeded into 6-well plate 
and subsequently cultured in an osteogenic induction media for 
21 days. Alizarin Red S staining was conducted for detecting 
calcium deposition and mineralization. Scale bars =250 µm. (B) 
Adipogenic differentiation. The same 3x105 cells seeded were 
cultured for 21 days in an adipogenic induction media 
supplemented with insulin. Oil Red O staining for detecting lipid 
accumulation was negative in monolayer, while morphogenic 
transformation was noticed. Scale bars =250 µm. (C) 
Chondrogenic differentiation. Total 2.5x105 cells were seeded 
into a 15ml conical tube for the pellet culture using chondrogenic 
induction media for 21 days. Alcian blue staining for detecting 
glycosaminoglycan secretion was positive and morphogenic 




































 The results of this study clearly demonstrate that bone 
marrow tissue of neonatal chicks was premature at least up to 4 
days after hatching. This tissue contains a variety of cells 
involved in endochondral ossification as well as mature bone 
marrow cells. The majority of these cells became cuboidal until 
the end of primary culture, and more than 80% of cells were 
Sox9-positive. The results of the differentiation induction 
suggest the feasibility of Sox9 for regenerating bone marrow 
tissues. 
 
In addition to the expression of specific markers for 
osteochondrogenesis, the expression of other markers, such as 
those associated with pluripotency, endothelial cells, 
hematopoietic cells, and mesenchymal cells, may indicate an 
amorphous structure of 4-day-old long bone (femur) tissue. 
Apparent differences between neonatal (hatched or 4-day-old) 
and adult femurs were detected, and a unique gene expression 
profile of neonatal bone marrow cells may be representative of 
cells and tissues undergoing endochondral ossification. This 
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tissue contains progenitor cells of osteogenesis, osteoclasts and 
macrophages, and blood vessel cells that trigger bone 
morphogenesis. The bone marrow cells of hatched or neonatal 
chicks, which contain a large number of Sox9-positive cells, can 
either directly support osteogenesis or secrete both 
chondrotrophic and osteotrophic factors in vitro. 
 
 Despite a mixed cell population, most cells collected at 
the end of P5 were Sox9-positive. Subculture of chick bone 
marrow cells may enable the vigorous proliferation of Sox9-
positive cells. Although a quantitative analysis was not 
performed, RT-PCR results demonstrated that Sox9 expression 
in P0 cells was weaker than that in P5 cells. Otherwise, a mixed 
culture of Sox9-positive cells with other cells may increase their 
action when they are co-cultured at least up to five times, and 
the culture of premature bone marrow cells can trigger certain 
cells with a specific function. These results are supported by our 
finding that the proliferation of endothelial cell- and 
macrophage-specific CD31-positive cells was strongly 
enhanced, and that all osteogenesis- and chondrogenesis-
related markers were expressed until P5. 
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Different culture systems may be specific to the 
proliferation of a specific cell type. The positive role of the 
culture system employed in this study in amplifying 
osteochondrognic cells was confirmed. The chick bone marrow 
cells established in this study directed their differentiation 
towards osteogenesis and chondrogenesis, not adipogenesis, 
which confirmed their specific expression for 
osteochondrogenesis-related genes and markers. Taken 
together with the results of histological, molecular, and 
cytological analyses, our results suggest the potential use of 
chick bone marrow cells as a basic biomaterial for clinical 
applications for injuries and degenerative diseases (Barry and 
Murphy, 2004; Dezawa et al., 2005; Nandoe Tewarie et al., 2006; 











CULTURE PROFILE FOR CHICKEN 
NEONATAL BONE MARROW CELLS 
AND CUSTOMIZATION FOR 





 Embryonic mesenchyme is a pivotal tissue of 
organogenesis and the mesenchyme-derived (mesoderm) cells 
retain the multipotency into committed cells (Hay, 2005), as long 
as have a pluripotent activity (Kitagawa and Era, 2010; Moon et 
al., 2011). I recently found that the bone marrow of neonatal (0- 
to 4-day-old) chicks is premature tissue, which derives a 
variety of the cells involving in endochondral ossification as well 
as of mature bone marrow cells. Furthermore, the neonatal bone 
marrow cells (nBMCs) collected from subculture mainly consist 
of Sox9-positive cells that prefer to differentiating into 
osteogenesis or chondrogenesis in vitro. 
 
 Number of questions might be answered for establishing 
nBMC-based biotechnologies by applying our results. First of all, 
it is urged to understand nBMC properties following in vitro 
culture for evaluating the necessity of culture system. 
Nevertheless, basic information on chicken bone marrow cells 
culture has not reported yet and a standard protocol of 
manipulation and cellular properties have not been established. 
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Furthermore, the feasibility of the culture environment should be 
confirmed in chicken bone marrow cells for both preclinical 
model researches and clinical application of novel 
biotechnologies. 
Second, if culture is useful, the customization of the nBMC 
culture system for maintenance, transformation and 
differentiation is required. Consequently, I first examined the 
origin of Sox9-positive cells; from intact BMCs or by in vitro 
culture? Also, we evaluated whether the nBMC subculture 
amplify Sox9-positive cells. Second, I customized the nBMC 
culture system for cell maintenance and ostrochondrogenic 
differentiation. Three conventional media without any 
supplementation except for serum were evaluated. Major criteria 
were how many subculture can be made for nBMCs without loss 
of cellular function. Various culture profiles and differentiation 
tendency were monitored and the gene and marker expressions 
for osteogenesis and mesenchymal cells were monitored. 
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2. Materials and Methods 
 
Experimental design and parameters 
 
General procedures of this study consisted of 1) the collection 
of the femur from 4-day-old chicken, 2) the isolation and 
preparation of nBMCs for in vitro-culture 3) the execution of the 
nBMC culture using different culture environments. The outcome 
of nBMC culture and the expression of genes and proteins were 
employed as the experimental parameters for understanding the 
relationship between culture and nBMC properties and for 
optimizing the culture system of cell maintenance and 
differentiation, respectively. The culture outcome was 
represented by cell morphology and number (both cumulative 
and actual number) at each passage up to P12, colony-forming 
activity, senescence after 5 times subculture and the P5 cell 
differentiation (osteogenesis, chondrogenesis and adipogenesis). 
Subsequently, the expression of specific genes (Sox9, Runx2, 
Col I, Col II, Col X and Aggrecan) and proteins (Sox9, Col I and 
Col II) for endochondral ossification were monitored in the P0 
and P5 cells by RT-PCR and immunocytochemistry, respectively. 
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Maintenance of nBMCs 
 
Chicken nBMCs were culture on the monolayer and subcultured 
when they reached 70-80%. Three basic media, high-glucose 
DMEM (high), low-glucose DMEM (low) and DMEM/F-12 were 
employed, to which 10% (v/v) FBS and 1% (v/v) antibiotics 
solution were supplemented. Cell culture was conducted at 37℃, 
5% CO2 in a humidified atmosphere. 
 
Assessment of chicken bone marrow cells senescence assay 
 
Cell survival and senescence of nBMCs cultured were evaluated 
using a Senescence ß-Galactosidase Staining Kit. At the end of 
P5, nBMCs cultured in different media were provided for the 





nBMCs collected from P0 and P5 were washed with PBS, fixed 
with 4% (v/v) paraformaldehyde and subsequently permeabilized 
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with 0.1% (v/v) of Triton X-100. After washing, the cells were 
blocked with 10% (v/v) normal goat serum and treated with Sox9, 
Collagen type I and Collagen type II antibodies overnight at 4℃. 
After being treated with secondary antibody for 2 hours at room 
temperature, the fixed cells were stained in DAPI staining 
solution. Images were captured via fluorescent microscopy using 








Whether the in vitro culture could expand the Sox9-rich nBMCs? 
 
Comparing marker reactivity (Figure 8), different expression 
was detected between the P0 and the P5 cells. The P0 cells 
expressed Sox9 and Col I, not Col II. Col II became expressed 
with Sox9 and Col I in the P5 cells. In the P0 cells (Figure 8A), 
most cell were positive for Col I (85.0±1.6%) and Sox9 
expression was within the range of 30.6±1.5%, regardless of 
media. In the P5 cells (Figure 8B), the percentage average of 
Sox9-positive, Col I-positive and Col II-positive cells to the 
total cell number was 91.7±0.5%, 64.3±3.6% and 34.4±3.4%, 
respectively. Significant (p=0.0042) effect of media was 
detected only in Col I expression and better expression was 
detected in low DMEM and DMEM/F12 than in high DMEM. Sox9 
expression were dominant in the P5 cell, while Col I in the P0. 
 
Whether the culture regime could be customized for enhancing cell 




Figure 8. Expression of specific marker proteins for 
ostechondrogenesis in the bone marrow cells retrieved from 4-
day-old chick femurs. Expressions of Sox9 and Sox9-related, 
collagen type I (Col I, fibrous cartilage marker) and collagen type 
II (Col II, proliferative chondrocyte marker) proteins were 
monitored in the bone marrow cells subcultured in different 
media, high glucose Dulbecco’s minimal essential medium (high 
DMEM), low glucose DMEM (low DMEM) or a nutrient mixture 
of DMEM or Ham’s F-12 medium (DMEM/F12). (A) Expression 
at the end of primary culture (P0) and their percentage of 
expression to total cultured cells. Only Sox9 and Col I were 
expressed, but the model effect of media on the expression was 
not detected in each markers. The percentage average of Sox9-
positive and Col I-positive cells to the total cell number was 30.6
±1.5% and 85.0±1.6%, respectively. (B) Expression at the end 
of P5. Expression of all three markers were detected. The 
percentage average of Sox9-positive, Col I-positive and Col II-
positive cells to the total cell number was 91.7±0.5%, 64.3±3.6% 
and 34.4±3.4%, respectively. Only Col I expression was greatly 
(p=0.0042 of model effect) influenced by the medium, while the 
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Comparing cell morphology, cuboidal cell became dominant 
population in the P5 cells regardless of culture media and as 
shown in Figure 9, no different morphology except for cell 
density was detected. Significant (p=0.0207) model effect was 
detected and more cells were maintained at the P5 in DMEM/F12 
than in high DMEM.  
 
 Media effect become apparent when nBMC subculture 
were extended up to P12. As shown in Figure 10A, more 
(p<0.0408) cells were retained after the subculture with 
DMEM/F12 than after the subculture with high DMEM and low 
DMEM except for P0 (p=0.313). The cell number accumulated 
became plateau between P5 to P7, which seemed to be earlier in 
high DMEM compared with DMEM/F12. Significant (p<0.0001) 
effect of subculture was also detected in the actual proliferation 
of nBMC at the end of each passage. As shown in Fig 10B, greater 
proliferation was detected in P2 and P3 than in other passages, 
regardless of culture media. Minimized proliferation were 
detected from P8 in high DMEM and from P10 in low DMEM and 
the DMEM/F12. No more increase in cell number by nBMC 
subculture was detected from P11 in high DMEM and P12 in low 
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DMEM and DMEM/F12. 
 
 As shown in Figure 11, no significant difference in total 
cell number was detected (p=0.4789) and the number of CFU 
colonies was not different among the media. However, significant 
(p=0.0229) model effect was detected in the size of the colonies 
and DMEM/F12 yielded the largest colony than any others. 
Senescence assay showed that less senescent cells were derived 
from the subculture in DMEM/F12 than from the subculture in 
high and low DMEM (Figure 12). Significant (p=0.046) model 
effect was detected. When monitored gene expression in the P5 
cells (Figure 13), all expressions of Sox9, Runx2, Col I, Col II, 
Col X and Aggrecan, the endochondral ossification-related genes 
tested in this study, were detected. Percentage of expression 
results show in the P5 cells were increased expression early 
osteochondrogenic related markers of Sox9 and Col I. Col II than 
P0 (Figure 14). As shown in Figure 15, both osteogenic and 
chondrogenic differentiation was detected. Significant 
(p=0.0058) model effect was detected in osteogenic 
differentiation and DMEM/F12 induced more than the others. 
Considering chondrogenic differentiation, larger mass of 
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Figure 9. Morphology of the bone marrow cells retrieved from 
the femur of 4-day-old chicks. The bone marrow cells were 
cultured in different media and were subcultured at P5. High 
glucose Dulbecco’s minimal essential medium (high DMEM), low 
glucose DMEM (low DMEM) or a nutrient mixture of DMEM or 
Ham’s F-12 medium (DMEM/F12) was employed for the culture 
of bone marrow cells. (A) Regardless of culture media, the major 
population of the P5 cells and no different morphology except for 
cell density was detected. Scale bar=100μm. (B) Quantitative 
comparison of the numbers of the P5 cells maintained in different 
media. Significant model effect of media was detected and more 
cells were maintained at the P5 in DMEM/F12 than high DMEM 










































Figure 10. Proliferation of the bone marrow cells retrieved from 
the femur of 4-day-old chicks following subculture in vitro. The 
bone marrow cells were cultured in different media, high glucose 
Dulbecco’s minimal essential medium (high DMEM), low glucose 
DMEM (low DMEM) or a nutrient mixture of DMEM or Ham’s F-
12 medium (DMEM/F12). Total cell number was counted at the 
end of each passage up to 12 and either cumulative cell number 
since P0 culture (A) or actual cell number at the end of each 
passage (B) was compared among the media. (A) Significant 
(p<0.0408) model effects of the media were detected from P1 
and DMEM/F12 yielded the largest cells. Actual cell number after 
culture in high DMEM (B1), low DMEM (B2) and DMEM/F12 
(B3). Significant (p<0.0001) model effect was detected in each 
parameter. Greater proliferation was detected in P2 and P3 than 
in other passages, regardless of the kinds of medium, while 
minimal proliferation was detected from P8 in high DMEM and 
from P10 in low DMEM and the DMEM/F12. Increase in cell 
number by subpassage was not detected from P11 in high DMEM 











Figure 11. Seeding efficiency of chick bone marrow cells 
retrieved from 4-day-old femur. The bone marrow cells were 
cultured in high glucose Dulbecco’s minimal essential medium 
(high DMEM), low glucose DMEM (low DMEM) or a nutrient 
mixture of DMEM or Ham’s F-12 medium (DMEM/F12). (A) One 
million cells retrieved at the end of primary culture were 
subsequently seeded into a well of 6-well plate and the cell 
number was counted at the end of the 7 day. (B1 and B2) 
Colony-forming activity of the bone marrow cells, which was 
evaluated by colony forming unit (CFU) analysis. One million 
cells retrieved at the end of primary culture were seeded into 
100-mm cell culture plate and crystal violet staining was 
performed to detect single cell-derived clones 14 days after 
culture. Positive staining was defined as a colony that contained 
50 positive cells on average. Significant (p=0.0229) model effect 
of media was detected and DMEM/F12 yielded the best forming 
activity (B2). The number of the CFU colonies were not different 































Figure 12. Senescence of the bone marrow cells cultured in three 
different media. The bone marrow cells retrieved from 4-day-
old chick femur were cultured in different media, high glucose 
Dulbecco’s minimal essential medium (high DMEM), low glucose 
DMEM (low DMEM) or a nutrient mixture of DMEM or Ham’s F-
12 medium (DMEM/F12). β-galactosidase (SA-β-Gal) was 
used for the senescence assay for the bone marrow cells 
cultured to passage 5 and the number of SA-β-Gal positive cells 
was counted. Significant model effect was detected and both low 
DMEM and DMEM/F12 yielded less senescent cells than high 
DMEM. Images showed the cells positive for SA-β-Gal or not. 





























Figure 13. Assessment of gene and protein expression of the 
bone marrow cells cultured in different media until passage 5 
(P5). The bone marrow cells retrieved from 4-day-old chick 
femur were cultured in different media, high glucose Dulbecco’
s minimal essential medium (high DMEM), low glucose DMEM 
(low DMEM) or a nutrient mixture of DMEM or Ham’s F-12 
medium (DMEM/F12). (A) RT-PCR analysis showing that 
ostengenic and chondrogenic related genes such as Runx2, Sox9, 
Col I, Col II, Col X, Aggrecan were expressed in the cells 
collected from P5. β-actin was positive control. Comparisons 
of protein expression analysis for the bone marrow cells 
collected at the end of primary culture (B) and the P5 cells (C). 
Western blot results showed Col II and Sox9 protein level 
increased in the P5 cells, while no or weak expression of Col II 

















A (At P5) B (Primary) 
C (At P5) 
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Figure 14. Immunocytochemistry analysis of the bone marrow 
cells retrieved from 4-day-old chick femur at passage 0 and 
cultured in different media until passage 5 (P5). (A) Surface 
antigen characterization of osteochondrogenic related marker 
such as Sox9, Col I, Col II expression. (B) Percentage of 
expression results show the bone marrow cells at passage 0 are 
expressed early osteochondrogenesis-related markers Sox9 
and Col I. Col II, a marker of advanced stage of development, was 
not expressed at passage 0. Statistically significant different 
were not observed among the groups. (C) Surface antigen 
characterization of osteochondrogenic related marker such as 
Sox9, Col I and Col II expressions. Model effect of media on the 
expression was not detected (p>0.1119). (D) Percentage of 
expression results show in the P5 cells were expressed early 
osteochondrogenic related markers of Sox9 and Col I. Col II, a 
marker of an advance stage of chondrogenesis was also 
expressed in the P5 cells. Significant (p=0.0042) model effect 
of media on the marker expression was only detected in Col I. 






























































Figure 15. Differentiation of the bone marrow cells cultured in 
different media until passage 5 (P5). The bone marrow cells 
retrieved from 4-day-old chick femur were cultured in different 
media, high glucose Dulbecco’s minimal essential medium (high 
DMEM), low glucose DMEM (low DMEM) or a nutrient mixture 
of DMEM or Ham ’ s F-12 medium (DMEM/F12). (A) 
Osteogenic differentiation. Total 3x105 cells at passage 5 were 
seeded into 6-well plate containing an osteogenesis induction 
medium and were subsequently cultured for 21 days. Alizarin 
Red S dye was used for the detection of differentiation. The 
morphology of the cultured cells was monitored under an 
inverted microscope. Significant (p=0.0058) model effect was 
detected and DMEM/F12 induced more osteogenic differentiation 
than the others. Data are presented as Mean±SE. Scale bars=200 
µm. (B) Chondrogenic differentiation. The 2.5x105 P5 were 
seeded into 15ml conical tube and pellet culture in a chondrogenic 
induction. Twenty-one days after culture, the cells were stained 
with Alcian blue dye. More induction was observed in DMEM/F12 





















Figure 16. Development of Chicken 4-day-old Sox9 positive cells. Schematic representation of Sox9 positive cells development and 









In chicken, various methods for culturing bone marrow 
cells have been studied. It has been reported in above 11weeks 
old chicken that culture environment and isolated cell 
characterization. In this study, use of 4-day-old chicken bone 
marrow derived cell compared with previous studies confirmed 
the applicability of the culture system. Since these two different 
age chickens are showed different cell morphology and 
characteristics, my results further expanded the feasibility of the 
4-day-old chicken bone marrow progenitor cells culture system 
for the research of various purpose.  
Endochondral ossification began with the deposition of 
collagen type I by cells derived from bone marrow on the surface 
of the eroded cartilage. The transcription factor Sox9 is essential 
for early chondrogenesis, and abnormal Sox9 expression causes 
severe abnormal regulation of endochondral ossification (Hata et 
al., 2017). SOX9 is involved in the control of the activation of 
Collagen II in chondrocytes, an essential signaling of the 
differentiation program (Lefebvre et al., 1997) (Figure 16). 
Two major findings were derived from the results of this 
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study. First, the subculture of neonatal bone marrow cells 
specifically amplifies both Sox9- and Col II-positive cells, which 
resulted Sox9-positive cells became dominant in the P5 cells, 
switching from the Col I dominant in nBMCs at the P0. Intact 
nBMCs contained considerable number of Sox9-positive cells 
(30% of total), but no Col II-positive cells were detected. 
Second, use of DMEM/F12 medium could optimize the outcome 
of nBMC subculture, which further contributed to customizing 
nBMC-mediated, differentiation protocol for both osteogenesis 
and chondrogenesis 
The nBMCs maintained by subculture were cuboidal, 
which appeared as early as from the primary culture. Considering 
the results of histological observation, the morphology, as well 
as cell fraction, of nBMCs might different from that of adult BMCs. 
Culture of adult BMCs usually yielded stromal cell-dominant 
population, while not in this study employing neonatal chicken. 
However, the results of this study demonstrated that media and 
culture protocols did not affect the morphology of nBMC 
maintained in vitro and cuboidal cells were dominant throughout 
the culture. Changing in basic culture media may majorly 
influence cellular activity.  
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 Apparent difference between the P0 cells and the P5 cells 
was osteochondrogenesis-related protein expression, which 
demonstrated that in vitro-manipulation of nBMCs might be 
beneficial for activating (or inhibiting) specific cell function of 
nBMCs. From the results of this study, nBMC culture can be used 
for preparing Sox9-positive fraction. Sox9-positive cells are a 
pivotal role in osteochondrogenesis, which is a progenitor cell of 
Col I-positive cells and Col II-positive cells. The co-expression 
of Sox9 and Col II was detected with that of Col I and Col II in 
the P5 cells which supported our finding that nBMCs maintained 
in vitro preferentially induced both osteogenic and chondrogenic 
differentiation, not adipogenic differentiation. 
 Use of DMEM/F12 as a basic medium for nBMC culture 
can be recommended from the results of this study. Noting no 
changing of gene expression profiles among the media tested in 
this study, changing of basic medium from high DMEM to 
DMEM/F12 mainly serves as the activator of cell proliferation. 
However, this beneficial function directly to enhance osteogenic 
or chondrogenic differentiations of nBMCs, although they were 
mixed population of the cells involving endochondral ossification 
and mesenchymal cells. Tissue regeneration requires lots of the 
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cells from different lineages and biomaterials for completion of 
matrix formation and function of the tissue engineered, and our 
results may suggest the contribution of nBMCs from different 
viewpoints.   
 









Effects of Basic Fibroblast Growth 
Factor (bFGF) on the Proliferation and 







Fibroblast growth factors (FGFs) involved in 
developmental pathways like mesoderm patterning during the 
early embryo through to the development of multiple organ 
systems (Nutt et al., 2001; Deimling and Drysdale, 2011). Also 
FGF signaling extends on many physiological roles in the adult 
organism, including the regulation of the angiogenesis and wound 
repair (Ishihara et al., 2006). The major function of FGF 
signaling in bone, FGF2 and FGF9 transcripts are found in 
mesenchymal cells and osteoblasts (Marie, 2003). FGF18 is 
expressed in mesenchymal cells, in differentiating osteoblasts 
during bone development and in the long bones (Ohbayashi et al., 
2002). 
Regenerative medicine is important as it can stop or slow 
the progression of disease. Biologic and cellular therapies help 
improve the efficiency of traditional tools and reduce the need 
for invasive surgeries. Sox9 positive cells in bone marrow, which 
are also known as osteochondrogenic progenitor cells, are 
considered as the basic material for clinical application to injuries 
and degenerative diseases. In osteo and chondro progenitor cells, 
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Sox9 as a transcriptional factor is a key regulator signaling that 
responsible for expression of Runx2, Collagen type I, Collagen 
type II, Collagen type X, aggrecan and the other multiple ECM 
related markers according to each differentiation lineage. For 
clinical implementation of sox9 positive cells, their more 
homogeneous isolation and abundant and stable maintenance is 
important for optimizing manipulation protocol of chicken sox9 
positive cells and the large-scale expanded culture system has 
been used to high reproducibility of cells. And also it become a 
valuable resource for cell-to-cell tissue regeneration and 
experimental modelling for differentiation and reprogramming.  
 
In mouse bone formation, overexpressed FGF2 signaling 
causes abnormal bone development, but its inhibition of this 
signal leads to malformation of bones (Iseki et al., 1997). Also 
FGF signaling regulates cell proliferation and osteoblast 
precursor cells replication into osteoblasts and controlled 
apoptosis of immature osteoblasts (Mansukhani et al., 2000). 
FGFs signaling interacts with other growth factors signaling and 
regulates osteoblast function. FGF2 and FGFR2 resulting in 
increased BMP4 activity, therefore can control cranial suture 
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fusion through BMP signaling (Kim et al., 1998). Activation of 
FGF signaling can regulate genes involved at full steps of 
osteogenesis. However, optimal concentration and role of the 
bFGF in promoting the proliferation of sox9 positive cells derived 
from chicken bone marrow has not been reported. In this study, 
I conducted to suggest the optimal concentration of bFGF on the 








In experiment 1, the sox9 positive cells retrieved from 4-day-
old chicks were subcultured and cell morphology and 
proliferation profile were monitored insertion on different 
concentrations of bFGF. In experiment 2, According to insertion 
of bFGF, the reactivity of the specific markers like sox9 and 
osteogenic and chondrogenic related gene expression of the P0 
and P5 cells were evaluated. The expression of specific genes 
for osteo-chondrogenesis (Sox9, Col I, Col II, Col X and 
Aggrecan) was subsequently monitored. In experiment 3, 
osteogenic and chondrogenic differentiation of the P5 cells was 
induced. And finally, I conducted on effect of bFGF to functional 
ability of sox9 positive cells. 
 
Assessing of cell proliferation during in vitro-culture of cells 
 
Cell number was monitored at the end of each passage up to 12 
passages according to different concentration of bFGF. Both the 
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cell number accumulated from primary passage were counted. 
Cell counting kit-8(CCK-8) analysis of the sox9 positive cells 
was detected at day 1, 3, 5, 7, 10. 
 
Scratch Wound healing assay 
 
The cells were seeded onto six-well plates and cultured at 37°C 
in a 5% CO2 cell incubator. After the cells reached 70%-80% 
confluence, scratch assay conducted upper to down direction 
carefully using a 200-μL sterile pipette tip. Then cell culture 
plates were washed three times with sterile PBS to remove the 
scratched cells. The cells were continuously cultured in serum-
free culture medium. After 18 h, the cells were photographed and 
detects the size of scratch recovery. Cell migration distance = 




The retrieved cell suspension is placed in upper chamber. Then 
after 24hours, invasive cell pass through basement membrane 
layer and cling to the bottom of the insert membrane. Non-
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invasive cells stay in the upper chamber. After removal of non-
invasive cells, invasive cells are stained using crystal violet and 







bFGF stimulates the proliferation of sox9 positive cells in vitro  
 
To investigate the effect and optimal concentration of bFGF on 
the proliferation of sox9 positive cells, I seeded the cells into 6-
well plates with culture medium supplemented with the different 
concentrations of bFGF (0, 1, 5 and 10 ng/mL) (Fig 17-A). 
Cumulative cell number at each passage for up to 12 passage was 
employed for statistical analysis. A significant model effect was 
detected from passage 6 and better proliferation was detected at 
5 or 10 ng/ml than 0 or 1 ng/ml. Asterisk indicate significant 
model effect (p<0.05). 
Furthermore, the CCK-8 data showed that, passage 5 bone 
marrow cells exposed continuously to 0, 1, 5 or 10 ng/ml bFGF 
were provided for CCK-8 assay on day 1, 3, 5, 7 and 10 of 
culture. Significant model effect was detected from day 7 of 
culture (Fig 17-B). 
 




Figure 17. Proliferation profile for up to passage 12 and cellular 
activity at passage 5 of 4-day-old, chick bone marrow cells. 
The bone marrow cells were cultured in nutrient mixture of 
DMEM/F12 medium, to which 0, 1, 5 or 10 ng/ml basic fibroblast 
growth factor (bFGF) was added, and the number of cells was 
counted at the end of each passage. (A) Cumulative cell number 
at each passage for up to 12 passage was employed for statistical 
analysis. A significant model effect was detected from passage 6 
and better proliferation was detected at 5 or 10 ng/ml than 0 or 
1 ng/ml. Asterisk indicate significant model effect (p<0.05) (B) 
The passage 5 bone marrow cells exposed continuously to 0, 1, 
5 or 10 ng/ml bFGF were provided for CCK-8 assay on day 1, 3, 
5, 7 and 10 of culture. Significant model effect was detected from 





















Morphology of the bone marrow cells at the end of passage 0 and 
5 was observed under an inverted microscope. Increased density 
of cuboidal cells was noticed after 1 or 5 ng/ml bFGF exposure 
compared with no exposure (Fig 18).  
 
bFGF effects on the Sox9 and osteogenic and chondrogenic 
related gene expression of cultured sox9 positive cells 
 
Expression of osteogenesis-related or chondrogenesis-related 
genes in sox9 positive cells. Quantitative RT-PCR was 
conducted to detect the expression of Sox9, Runx2, Collagen 
type I, Collagen type II, Collagen type X and Aggrecan. 
Significant model effect was detected in all genes evaluated and 
exposure to bFGF increased gene expression. However, the 
optimal level of exposure is different (Fig 19). Detection of Sox9 
expression in cultured cells at the end of passage 5 culture by 
immunocytochemistry. 0, 1, 5 or 10 ng/ml basic fibroblast growth 
factor (bFGF) was added and Sox9 expression were monitored. 
There were no significant model effects of different 




Figure 18. Morphology of 4-day-old, chick bone marrow cells 
exposed to basic fibroblast growth factor (bFGF) after being 
retrieved from the long bone. The bone marrow cells were 
seeded to a 100-mm culture dish and subsequently cultured in 
nutrient mixture DMEM/F12 medium, to which 0, 1, 5 or 10 ng/ml 
bFGF was added. Morphology of the bone marrow cells at the 
end of passage 0 and 5 was observed under an inverted 
microscope. Increased density of cuboidal cells was noticed after 















Figure 19. Expression of osteogenesis-related or chondrogenesis-related genes in 4-day-old chick bone marrow 
cells. The bone marrow cells were cultured for up to 5 passage in nutrient mixture of DMEM/F12 medium to which 0, 
1, 5 or 10 ng/ml basic fibroblast growth factor (bFGF) was added and quantitative RT-PCR was conducted to detect 
the expression of Sox9, Runx2, Collagen type I, Collagen type II, Collagen type X and Aggrecan. Significant model 
effect was detected in all genes evaluated and exposure to bFGF increased gene expression. However, the optimal 












Figure 20. Detection of Sox9 expression in 4-day-old, chick 
bone marrow cells at the end of passage 5 culture by 
immunocytochemistry. The bone marrow cells were cultured in 
nutrient mixture of DMEM/F12 medium to which 0, 1, 5 or 10 
ng/ml basic fibroblast growth factor (bFGF) was added and Sox9 
expression were monitored. There were no significant model 
effects of different concentration of bFGF on each expression. 

















bFGF stimulates the differentiation ability of sox9 positive cells in 
vitro 
 
In osteogenic differentiation, calcium deposition and 
mineralization were detected in monolayers. More differentiation 
was detected at 5 ng/ml and 10ng/ml than at other levels (Fig 
21). And also chondrogenic differentiation, signals on 
differentiation showing blue color was weak, but noticeable at 
certain level of bFGF (Fig 22). 
 
bFGF effects on the invasion assay and transwell cell migration of 
cultured sox9 positive cells 
 
The invasion assay and transwell cell migration provides 
thorough analysis of the ability of cells to sense a particular 
chemo-attractant and migrate through a physical barrier toward 
it (Justus et al., 2014). Exposure of 1 and 5 ng/ml bFGF to the 
bone marrow cells subcultured improved migration ability, which 
was evaluated by the response to scratch 18 hours after damage 
(p=0.0084) (Fig 23-A). And quantification of the bone marrow 
cell invasion through matrigel and transwell membrane. Exposure 
125 
 
of 5ng/ml bFGF improved invasion activity of sox9 positive cells 





Figure 21. Osteogenic differentiation of 4-day-old, chick bone 
marrow cells after being exposed to basic fibroblast growth 
factor (bFGF) throughout subculture. The bone marrow cells 
were cultured in nutrient mixture of DMEM/F12 medium, to 
which 0, 1, 5 or 10 ng/ml bFGF and the passage 5 cells were 
provided for osteogenic differentiation. (A) Osteogenic 
differentiation. The 3x105 bone marrow cells were seeded into 
6-well plate containing an osteogenic induction medium and 
subsequently cultured for 21 days. Alizarin Red S staining was 
conducted for the differentiation, while morphogenic 
transformation was observed under an inverted microscope. 
Calcium deposition and mineralization were detected in 
monolayers. More differentiation was detected at 5 ng/ml and 
10ng/ml than at other levels. Scale bars =200 µm. (B) Numerical 
comparison by using of densitometry showed a significant model 
effect. Either 5 or 10 ng/ml bGFG was optimal. Data are 






























Figure 22. Chondrogenic differentiation of 4-day-old, chick 
bone marrow cells after being exposed to basic fibroblast growth 
factor (bFGF) throughout subculture. The bone marrow cells 
were cultured in nutrient mixture of DMEM/F12 medium, to 
which 0, 1, 5 or 10 ng/ml bFGF and the passage 5 cells were 
provided for osteogenic differentiation. (A) Chondrogenic 
differentiation. The 2.5x105 bone marrow cells were seeded into 
15-ml conical tube for pellet culture using a chondrogenesis 
induction medium for 21 days. Alcian blue staining was used for 
glycosaminoglycan, a secretory product of chondrocyte, 
detection. Morphogenic transformation was monitored under an 
inverted microscope. Signals on differentiation showing blue 
color was weak, but noticeable at certain level of bFGF. (B) 
Numerical comparison by using of densitometry showed a 
significant model effect. One ng/ml bGFG showed prominent 
differentiation than other bFGF level. Data are presented as Mean





















Figure 23. The ability of cell migration and invasion in 4-day-
old, chick bone marrow cells after being exposed to basic 
fibroblast growth factor (bFGF) throughout subculture. The bone 
marrow cells were cultured in nutrient mixture of DMEM/F12 
medium, to which 0, 1, 5 or 10 ng/ml bFGF and the passage 5 
cells were provided for the analysis. (A) Wound healing assay of 
chicken OCPCs for assessing cell migration ability. (B) 
Quantification of cell migration activity. Exposure of 1 and 5 
ng/ml bFGF to the bone marrow cells subcultured improved 
migration ability, which was evaluated by the response to scratch 
18 hours after damage. (C) Transwell invasion assay of the bone 
marrow cells being exposed to bFGF. (D) Quantification of the 
bone marrow cell invasion through matrigel and transwell 
membrane. Exposure of 5ng/ml bFGF improved invasion activity 
of bone marrow cells. Data are presented as Mean±SE and 
























In recent years, bone marrow cells have been 
investigated as promising candidates for use in cell-based 
therapeutic strategies such as disease and regenerative medicine.  
This study was conducted to confirm the effectiveness of basic 
fibroblast growth factor (bFGF) for expanding chicken bone 
marrow-derived cells (BMCs). Basic fibroblast growth factor 
(bFGF) is a member of the FGF family and is a critical component 
of stem cell culture field(Sotiropoulou et al., 2006; Colenci et al., 
2014). However, the role and optimized concentration of bFGF 
on promoting the proliferation of MSCs derived from chicken 
bone marrow (BM) has not been reported. This study aimed to 
investigate the optimal concentration and the role of bFGF on the 
cellular activity of bone marrow cells derived from chicken, 
which may provide prominent guideline for addictiveness and 
possibility of the cell applications in regenerative medicine. bFGF 
related research has studied the optimal concentration on 
proliferation of different origin of the cells. Like dental pulp cells 
and apical papilla stem cells were concluded to be 100 ng/mL and 
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5 ng/mL respectively (Shimabukuro et al., 2009; Wu et al., 2012). 
Like these results and this study using chicken as an 
experimental animal suggest that an optimal concentration of 
bFGF on cellular activity must be optimized in each different 
types of cell line (Lee et al., 2015).  
To monitor the influence of bFGF effects on retrieved 
cells in vitro, proliferative capacity, cell morphology, gene 
expression, immunophenotype and differentiation potential and 
functional test like cell migration and invasion assay were 
evaluated as experimental parameters. During the prolonged 
subculture, cumulative cell number significantly incensement 
detected from passage 6 in the insertion of above 5ng/ml bFGF 
DMEM/F12 group (p<0.05). In CCK-8 assay, significant model 
effect was detected from day 7 of culture (p<0.05). From this 
results, bFGF is responsible for the proliferation of chicken bone 
marrow cells but the underlying molecular regulatory mechanism 
are still not well understood and thus need further study about 
the proliferation related specific antibodies. However, from now 
on no specific antibodies against chicken are commercially 
available at the present, this research was limited. In gene 
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expression analysis, osteogenesis and chondrogenesis related 
genes were more expressed in exposure of above 5 ng/ml bFGF.  
In example of study using MSCs, bFGF treatment will 
induce condrogenesis and osteogenic differentiation (Chiou et al., 
2006; Ito et al., 2008; Kim et al., 2011). Osteogenic 
differentiation was significantly incensement (p<0.0001) 
detected on insertion of more 5 ng/ml bFGF and chondrogenic 
differentiation was apparently detected on addition of 1 ng/ml 
bFGF. In migration and invasion assay, exposure of 5 ng/ml bFGF 
improved each activity. In conclusion, this study suggests that 
addition of 5 ng/ml bFGF in vitro on chick osteochondro 
progenitor cells has effectiveness on proliferation, differentiation, 














Effects of Stem Cell Culture 
Environments on the Cellular 








Mesenchymal-derived, multipotent cells have become a 
valuable resource for cell-to-tissue regeneration and 
experimental modelling for differentiation and reprogramming 
(Bianco et al., 2001; Anbari et al., 2014; Yan et al., 2014). In the 
chicken, bone marrow-derived cells can induce somatic 
chimerism (Heo et al., 2011; Heo et al., 2012) and if their 
pluripotency was confirmed, they could be used as resources to 
expand the applications of chicken pluripotent cells for various 
purposes(Jiang et al., 2002; Bhuvanalakshmi et al., 2014). To 
date, however, basic guidelines for the manipulation of bone 
marrow-derived cells has not been established. No information 
on culture properties have been reported because of their 
heterogeneous phenotype and mixed cell population (Ratajczak 
et al., 2004).  
 
Based on information obtained from research in mammals 
(Muraglia et al., 2000; Conget et al., 2001; Bosnakovski et al., 
2005), chicken bone marrow cells are comprised of population 
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may contain various undifferentiated progenitors and precursors, 
which could provide enormous information on cell differentiation 
using an ex vivo system (Friedenstein et al., 1987; Pittenger et 
al., 1999; Csaki et al., 2007).  
 
In this study, primordial germ cell media (PGC) as 
embryonic stem cell culture environment was introduced to 
increase the number of cells of different characteristics among 
the mixed population of primary bone marrow cells and the 
expression of the pluripotent and germness related genes. 
Embryonic stem cell culture environment contains various 
promoting factors for cell viability, which may help to maintain 
stem cell related characteristics or to facilitate of progenitor cells.  
 
 Given these observations, I presumed that chicken bone 
marrow contains various types of cells, and I conducted the 
present study to expansion of stem cell-like cellular properties 
in primary bone marrow cells through using stem cell culture 
medium. From this study, I obtained information on various 
aspects of primary cell culture. 
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In experiment 1, the bone marrow cells retrieved from 4-day-
old chicks were subcultured and colony forming ability and 
proliferation profile were monitored. Actual colony forming time 
period reduced 7days.  The time of seeding and actual cell 
number counted at the end of each subpassage were employed 
using each different culture medium. In experiment 2, the 
reactivity of the P5 cells to the specific markers for 
representative stromal cell marker (CD44) and 
osteochondrogenesis (Sox9, Col I, Col II and AP) and gene 
expression were evaluated. The expression of specific genes for 
pluripotency (pouV, Nanog and Sox2) and osteo-
chondrogenesis (Sox9, Col I, Col II, Col X and Aggrecan) was 
subsequently monitored. In experiment 4, osteogenic, adipogenic 





Western blot analysis was conducted to monitor the expression 
of specific proteins for CD44 and Collagen type II. Cellular 
proteins were extracted using lysis buffer [10mM Tris-HCl 
(PH7.4), 150Mm NaCl, 2.5Mm EDTA, and 0.125% Nodidet P-
40(v/v)] supplemented with both a protease inhibitor cocktail 
(Sigma Aldrich, St. Louis, MO). Twenty µg protein lysates were 
electrophoresed with SDS-PAGE and transferred onto 
polyvinylidene difluoride membrane (Millipore Corp., Bedford, 
MA). Membrane was blocked with Casein (0.5% w/v) prior to 
exposure to each antibody. Immnoreactivity was visualized by 
incubation with horseradish peroxidase-linked secondary 
antibody followed by exposure to Electrochemiluminescence 
reagent according to manufacturer’s instructions (GE Healthcare 







Comparisons of colony forming ability of nBMCs in various media  
 
 To evaluate of bone marrow derived primary cells 
attachment, colony forming unit-fibroblast analysis were 
conducted. One million bone marrow cells retrieved from primary 
passage were seeded into 100 mm cell culture plate and crystal 
violet staining was performed to detect single cell-derived 
clones during 7 days of culture. Positive staining was defined as 
a colony that contained 55 positive cells on average. As the 
results, in different three types of media significant difference 
were detected (p=0.0016, p<0.0001) (Figure 24 A 1-2). 
 
Proliferation of nBMCs 
 
 Proliferation of nBMCs in different three types of medium 
are detected by continuous subculture in vitro. Total number of 
subcultured cells are counted at the end of each passages. Total 
number of counted cells are cumulative in each passages.  
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Figure 24. Colony-forming activity of chick bone marrow cells. 
The number and size of the CFU colonies were significantly 
difference among the media (p=0.0016, p<0.0001) (A1-2). The 
bone marrow cells were cultured in different media, Primordial 
germ cell medium (PGC medium), low glucose DMEM (low 
DMEM) or a nutrient mixture of DMEM or Ham’s F-12 medium 












Cumulative number of cells at each passages are significant 
difference detected in each media. From passage 0, until passage 
12 significant difference are detected in each media. Bone 
marrow derived cells are cultured in PGC medium have better 
proliferation ability than other types of medium (Figure 25 A). 
Actual cell number detects significant (p<0.0001) model effect 
in each parameters and vigorous proliferation was gradually 
decreased from passage 4 or 5 (Figure 25 B 1-3). 
 
Assessment of gene expression and specific marker proteins for 
stromal cell marker (CD44) and osteo and chondrogenic related 
marker (Collagent type II) in the nBMCs cultured on different 
medium 
 
 Gene expression of nBMCs were assessed at passage 0, 
4 (Figure 26). RT-PCR analysis showing that pluripotent related 
marker (Pou V, Nanog, Sox2) and osteogenic and chondrogenic 
related genes such as Sox9, Runx2, Col I, Col II, Col X, Aggrecan 
were expressed in regardless of culture media. 
Immunocytochemistry and western blot analysis of chicken  
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Figure 25. Proliferation of the bone marrow cells retrieved from 
the femur of 4-day-old chicks following subculture in vitro. The 
bone marrow cells were cultured in different media, primordial 
germ cell medium (PGC medium), low glucose DMEM (low 
DMEM) or a nutrient mixture of DMEM or Ham’s F-12 medium 
(DMEM/F12). Total cell number was counted at the end of each 
passage up to 12 and either cumulative cell number since P0 
culture (A) or actual cell number at the end of each passage (B) 
was compared among the media. (A) Significant (p<0.0191) 
model effects of the media were detected from P0 and PGC 
medium yielded the largest cells. Actual cell number after culture 
in PGC medium (B1), low DMEM (B2) and DMEM/F12 (B3). 
Greater proliferation was detected in P3 than in other passages, 
regardless of the kinds of medium, while incensement of cell 


































nBMCs at passage 0 and passage 3. Expression of CD44 (stromal 
cell marker) and collagen type II (proliferative chondrocyte 
marker) proteins in 4-day-old chick bone marrow cells 
collected from passage 0 and passage 3 (Figure 27 A-1, B-1). 
Immunofluorescence staining of CD44 and collagen type II at 
passage 0. Collagen type II-positive cells (stained red) 
expressed on cultured in DMEM/F12 and Low DMEM. CD44-
positive cells (stained green) only expressed in PGC medium 
cultured cells. (Figure 27 A-2, B-2) In western blot analysis 
results, collagen type II was not expressed on cultured cells 
using PGC medium and CD44 as expressed regardless of culture 
media. 
 
Comparison of Differentiation activity of the bone marrow cells 
cultured in different media until passage 5 (P5) 
 
As shown in Figures 28 and 29, both osteogenic and 
adipogenic differentiation were detected. Differentiation of 4-
day-old chick bone marrow-derived cells collected from 
passage 5 using PGC media and Low glucose DMEM. Osteogenic 
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differentiation. Passage 5 cells of 3x105 were seeded into 6-well 
plate and subsequently cultured in an osteogenic induction media 
for 21 days. Alizarin Red S staining was conducted for the 
differentiation, while morphogenic transformation was detected 
under an inverted microscope. Calcium deposition and 
mineralization were detected in monolayer observation. After 
three weeks of osteogenic differentiation, nBMCs induced using 
PGC medium and Low DMEM media showed a significantly 
similar calcium deposit and the results effects on Alizarin Red S 
staining (p=0.0862). And in adipogenic differentiation, same 
3x105 cells were seeded and cultured in an adipogenic induction 
media supplemented with insulin for 21 days. After three weeks 
of adipogenic differentiation, nBMCs induced using PGC medium 
showed a significantly more lipid deposit than Low DMEM media 





Figure 26. Expression of pluripotency- and osteogenic or 
chondrogenic-related genes in 4-day-old chick bone marrow-
derived cells collected from the femur and the tibia. The cells 
collected at the end of passage 0 (A) and 4 (B) were provided 
for RT-PCR. (A) RT-PCR analysis showing that pluripotency-
related genes such as pouV, Nanog, Sox2 were not expressed. 
Osteo-chondrogenic genes of Sox9 and its downstream genes 
such as Collagen type I, II, X were concomitantly expressed. β















Figure 27. Expression of CD44 (stromal cell marker) and 
collagen type II (proliferative chondrocyte marker) proteins in 
4-day-old chick bone marrow cells collected from passage 0 
and passage 3. (A-1, B-1) Immunofluorescence staining of 
CD44 and collagen type II at passage 0. Collagen type II-positive 
cells (stained red) expressed on cultured in DMEM/F12 and Low 
DMEM. CD44-positive cells (stained green) only expressed in 
PGC medium cultured cells. (A-2, B-2) In western blot analysis 
results, collagen type II was not expressed on cultured cells 
using PGC medium and CD44 expression were expressed 


















Figure 28. Differentiation of 4-day-old chick bone marrow-
derived cells collected from passage 5 using PGC media and Low 
DMEM. Osteogenic differentiation. Passage 5 cells of 3x105 were 
seeded into 6-well plate and subsequently cultured in an 
osteogenic induction media for 21 days. Alizarin Red S staining 
was conducted for the differentiation, while morphogenic 
transformation was detected under an inverted microscope. 
Calcium deposition and mineralization were detected in 











Figure 29. Differentiation of 4-day-old chick bone marrow-
derived cells collected from passage 5 PGC media and Low 
DMEM. Adipogenic differentiation. The same 3x105 cells were 
seeded and cultured in an adipogenic induction media 
supplemented with insulin for 21 days. Oil Red O staining for the 
differentiation was negative and lipid accumulation was not 
detected in monolayer, while morphogenic transformation was 














In previous study found that 4-day-old WL are different 
developmental stage and so it contains a variety of cell. I 
explored cell identification and a suitable culture environment 
based on the analysis of cell characteristics of sox 9 positive 
cells. However, based on the differences in the genes and cell 
specific characteristics related to the pluripotency of cells from 
the common bone marrow origin, the research was carried out 
by introducing substances that are widely used in stem cell 
culture. In this study, I compared the growth function and cell 
characteristics of cells derived from the bone marrow of the day 
4 chicken with primordial germ cell culture medium similar to the 
composition of stem cell culture media. In stem PGC medium, 
they contain various promoting factors for cell viability and 
cellular properties such as chicken serum and bFGF.  
 
In chicken stem cell culture, Knockout Dulbecco’s 
modified Eagle’s medium (Knockout DMEM or KO/DMEM) is a 
basic culture medium which can support the growth ability in 
vitro. Although DMEM based culture medium can support the 
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growth of various type of stem cells, the composition of 
KO/DMEM is suitable for all kinds of mammalian and non-
mammalian stem cells and optimized culture environment of their 
growth rate (van de Lavoir and Mather-Love 2006; Amit and 
Itskovitz-Eldor 2016). Traditionally, the presence of fetal 
bovine serum (FBS) in KO/DMEM has been commonly used in 
cell proliferation due to the presence of growth factors. The fetal 
bovine serum routinely used for mouse embryonic stem cell 
culture may not be optimized for chicken cell culture environment; 
because of the fetal environment from which the FBS is derived 
is rich in growth factors (Horiuchi et al. 2006). One of the 
fundamental problems with using FBS or chicken serum is that 
they are both very complex because they contain unknown 
compounds, including self-reproduction and differentiation 
factors. (Skottman and Hovatta 2006). 
 
The above results clearly demonstrate that under the 
regimen used in the present study, the culture of newborn 
chicken bone marrow tissue yielded both stromal and cuboidal 
cell- dominant populations. The culture of chicken bone marrow 
cells differs in many ways from that of mammalian bone marrow 
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cells, which usually exhibit a fibroblast-like, stromal cell 
morphology (Toma et al., 2001; Bosnakovski et al., 2005). The 
retrieved cells using PGC medium were maintained up to at least 
the third passage, and a number of differences in cell specific 
protein expressions were observed compared with sox9 positive 
cells optimized cultured environments. Characterization of 
retrieved cells that shows different cellular properties also 
needed. Optimization of the culture system and an analysis of the 
unique properties of chicken bone marrow cells will be essential 
to promote the use of chicken cells collected from the bone 
marrow. 
 
This results may be due to differences in cell proliferation 
dynamics according to the maturity of the individuals between 
the two cell populations. Nevertheless, regardless of cell type, 
chicken bone marrow cells of various morphologies can be 
cultured and maintained in vitro to a certain extent. The PGC 
culture environment acts as exhibited better proliferation than 
the optimal compositions of sox9 positive population during 
culture. The various growth factors in the PGC culture medium 
and the culture environment suitable for growth of stromal cells 
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in the bone marrow can be seen to produce these results. And 
stromal cell marker like CD44 is expressed on only PGC medium 
culture environment. Chicken bone marrow cells have different 
characteristics compared with bone marrow cells of mammalian 
species, which usually yield a fibroblast-dominant population. 
Considering the mixed population of bone marrow cells, a 
different regimen may be needed for the outgrowth of chicken 
bone marrow-derived fibroblasts. Modification of the regimen 
used for the culture of bone marrow cells from mammals is 
necessary for the outgrowth of fibroblasts. In any case, the 
results of this study will make it possible to characterize chicken 
bone marrow cells of various types further and will increase the 











Effect of Bioactive Substances Derived 
from Chick Bone Marrow Cells on the 
Differentiations of Human Adipose-





Cell niche can maintain healthy condition and regulate the 
mechanisms that stem cell self-renewal or differentiation 
abilities (Blanpain et al., 2004). Some cell microenvironment or 
morphogenetic factors can be influenced cell characteristics. 
Recently, many studies have focused on using natural or 
synthetic biomaterials to create niches or micro-environments 
to control the behavior of the target cells and their cell 
characteristics like proliferation and differentiation (Lutolf and 
Hubbell, 2005; Peerani and Zandstra, 2010).  
 
Over the past few years, many study groups have studied 
using conditioned media to evaluate efficiency as a generative 
biomarker. Released protein from conditioned media by cultured 
cells is a rich source of materials for biomarker as an application 
of novel treatment. Recent studies suggested that morphogenetic 
signals from chondrocytes regulate differentiation into 
chondrogenic lineages and controlling the endochondral 
ossification during skeletal formation process. Conditioned media 
refers to the soluble factors like proteins that contain 
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morphogenic signals and are processed via the endoplasmic 
reticulum and Golgi apparatus through the cell secretion pathway. 
More generally, secretrome contains proteins that fall off the 
surface of cells and proteins released through exosomes. These 
secreted proteins include numerous enzymes, growth factors, 
cytokines and hormones or other soluble mediators. 
 
Adipose derived mesenchymal stromal cells (ADSCs) are 
a potential cell source for tissue engineering applications with 
bone or cartilages related diseases and regenerative medicine 
field. However, controlling differentiation potency and wanted 
target lineage formation in vivo remains a challenge. And tissue 
engineering as a clinical application has limitation and inefficiency 
by proliferation and differentiation sustaining. In these reasons, 
there is strong necessity for well-defined and improved 
protocols for directing cell characteristics in vivo.  
 
In these experiments, I hypothesized that morphogenetic 
signals from chicken sox9 positive cells would regulate ADCSs 
differentiation ability. From these results, I demonstrate that 
morphogenetic signals from chicken bone marrow cells, in the 
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form of soluble factors, induce as osteogenic differentiation 
enhancer of human ADSCs during in vitro differentiation. This 
results suggest possibility of the conditioned media as the 
morphogenetic factors from bone marrow cells to differentiation 
induction agents or reprogram cells for in vivo bone tissue 
engineering applications. ADSCs expanded in chicken bone 
marrow derived osteogenic differentiation conditioned medium 
enhanced osteogenic differentiation compared by routine 
protocol method. In addition, incubation of ADSCs with 
conditioned medium supplemented with osteogenic factors or by 
oneself induced more osteogenesis and accumulation of calcium 
and increased ALP activity. These findings reveal that chicken 
bone marrow cell derived secretion factors promote 
osteogenesis of ADSCs during in vitro differentiation culture.  
Given the current inefficient in vitro human cell 
differentiation protocols, this method and results develop a 
simple and innovative differentiation method for generating in 









The sox9 positive cells retrieved from 4-day-old chicks were 
subcultured and at passage 5 cells were seeded into 175T flask. 
At 80% cell confluences, these cell were inducted into osteogenic 
lineages during 3weeks. At the end of the differentiation culture 
media changed by serum free environment. After 3 days 
incubation, total media collected and filtered under 3Kd protein 
using ultra centrifuge. Then total protein was detected using 
Elisa-kit (Figure 30). 
In experiment 1, Checking protein levels in conditioned media 
using Elisa detection kit. Detection of TGF- β and hyaluronic 
acid (HA) and Bone morphogenetic protein 4 (BMP-4) using 
ELIZA. In experiment 2, Proliferation activity was evaluated in 
each different type of conditioned media using the Ki-67 
antibody. In experiment 3, the effect of bone deformation using 
conditioned media was explored by creating various 












Cell culture and conditioned medium 
 
At passage 5 cells seeded into 175T flask. When bone marrow 
derived cells reached to more than 80% confluence (at the end 
of P5), induction of   osteogenic differentiation begins for each 
1 and 2 weeks. End of each differentiation period, chicken bone 
marrow cells culture media changed with serum-free DMEM for 
3days. Then bone marrow cells-conditioned medium was 
filtered through 3Kd cut off filter tube to concentrate and prevent 
any cell contamination. 
 
Protein detection using elisa Kit analysis 
 
TGF-β detection 
Chicken TGF-β detection assay use double-sandwich elisa 
technique. Supplied plates were Pre-coated with chicken TGF-
β monoclonal antibody and the detecting antibody is biotin labeled 
polyclonal antibody. Samples and biotin labeling antibody are 
added into ELISA plate wells and washed out with PBS or TBS. 
Then Avidin-peroxidase conjugates are added to ELISA wells in 
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order. Use 3,3’,5,5’ - tetramethylbenzidine (TMB substrate) for 
coloring after reactant thoroughly washed out by PBS or TBS. 
TMB turns into blue in peroxidase catalytic and finally turns into 
yellow. Then color depth reads optical density(OD) at 450nm 
within 10min. 
 
Bone morphogenic protein-4 (BMP-4) detection 
BMP-4 ELISA kit use also sandwich enzyme immunoassay 
technique. The assay plate has been pre-coated with a 
monoclonal antibody specific for BMP-4. In order to 
quantitatively determine the amount of BMP-4 present in the 
sample, a standardized preparation of horseradish peroxidase 
(HRP)-conjugated polyclonal antibody. The enzyme-substrate 
reaction is terminated by addition of a sulphuric acid solution and 
the color change is measured spectrophotometrically at a 
wavelength of 450 nm.  
 
Hyaluronic acid (HA) detection 
HA ELISA kit applies the competitive enzyme immunoassay 
technique utilizing a monoclonal anti-HA antibody and an HA-
HRP conjugate. The assay sample and buffer are incubated 
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together with HA-HRP conjugate in pre-coated plate for one 
hour. After the incubation period, the wells are decanted and 
washed five times. The wells are then incubated with a substrate 
for HRP enzyme. The product of the enzyme-substrate reaction 
forms a blue colored complex. Finally, a stop solution is added to 
stop the reaction, which will then turn the solution yellow. The 
intensity of color is measured spectrophotometrically at 450nm 




ADSCs were cultured with each different types of conditioned 
media during 3days. Then washed with PBS, fixed with 4% (v/v) 
paraformaldehyde and subsequently permeabilized with 0.1% 
(v/v) of Triton X-100. After washing, the cells were blocked 
with 10% (v/v) normal goat serum and treated with Ki-67 
antibody overnight at 4℃. After being treated with secondary 
antibody for 2 hours at room temperature, the fixed cells were 
stained in DAPI staining solution. Images were captured via 






Protein levels in conditioned media using Elisa detection kit.  
 
We collected morphogenetic factors from chicken bone 
marrow cells differentiation stage cells with serum-free DMEM 
for 3days. Bone marrow cells-conditioned medium was filtered 
through 3Kd cut off filter tube to concentrate and prevent any 
cell contamination. Checking protein levels in proliferation and 
differentiation conditioned media using Elisa detection kit. 
Protein detection result of TGF- β, HA and BMP-4 show 
conditioned media contained small scale of protein (Table 2). 
 
Effect of conditioned media on proliferation and Osteogenic 
differentiation  
 
First, to determine if conditioned media would also be 
induced cell proliferation ability, morphogenetic factors produced 
from bone marrow cells were supplemented with cell 
proliferation assay using ki-67 antibody (Fig. 31). 
Second, to determine the effects of cell-secreted  
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Table 2. Checking protein levels in proliferation and 
differentiation conditioned media using Elisa detection kit. 
Detection of TGF- β and hyaluronic acid (HA) and Bone 
morphogenetic protein 4 (BMP-4) using ELIZA.  
 
I. TGF-beta detection 
Types of Conditioned Media Quantity of Detection (pg/ml) 















Mean±SE 52.18 pg/ml 
II. Hyaluronic Acid (HA) detection 
Types of Conditioned Media Quantity of Detection (pg/ml) 















Mean 99.9 pg/ml 
III. BMP-4 detectiion 
Types of Conditioned Media Quantity of Detection (pg/ml) 























Figure 31. Proliferation activity was evaluated in each different 
type of conditioned media using the Ki-67 antibody. 100 mg/ml 
of total protein used in this assay. The percentage of ki-67 
expression was in cultured cells monitored under an 
immunofluorescence microscope. (A-B) Significant difference 
was not detected (p=0.0758) in all of the groups, but 1week, 
2week conditioned media induced more osteogenic 
















morphogenetic factors on ADSCs osteogenesis, ADSCs were 
cultured with conditioned DMEM supplemented with 10% FBS. 
Medium without morphogenetic factors was used as control. At 
day 8, ADSCs cultured in conditioned medium detected more 
calcium deposits compared to control group (Fig. 32 A and B). 
Similarly, when differentiated into 2weeks, ADSCs cultured in 
conditioned medium detected also more calcium deposits 
compared to control group (Fig. 33, 34). Osteogenic activity of 
the morphogenetic factors secreted by chondrocytes was 
confirmed by strong ARS staining. Taken together, the above 
results indicated that 100ug/ml conditioned medium acts as a 
positive enhancer of osteogenesis during in vitro differentiation.  
 
Effect of conditioned media by the modified protocol which is 
without Dexamethasone on Osteogenic differentiation  
 
Human ADSCs osteogenesis was induced by routine 
protocol which contains components including beta-
glycerophosphate, dexamethasone, and ascorbic acid. ADSCs 
osteogenic differentiation method modified which is without 
dexamethasone and adding 100 mg/ml of each type of conditioned  
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Figure 32. Differentiation of the human ADSCs using different 
types of conditioned media. Four-day-old white leghorn chicks 
were employed as the donor of bone marrow cells and the 
isolated cells collected from the femurs were subsequently 
cultured in 10%(v/v) fetal bovine serum-containing, 
DMEM/F12-based media and differentiated into osteogenic 
3weeks. End of the differentiation period, the cells were newly 
cultured in serum-free DMEM/F12 medium and the media used 
for serum-free culture were collected 3 days after culture. 
These Collected media were concentrated until total protein 
concentration reached to 100 mg/ml. Then human ADSCs 
osteogenesis was induced either by routine protocol or by the 
protocol using 100 mg/ml of total protein until 8days. (A) 
Significant (p<0.0001) model effect was detected and 1week 
conditioned media induced more osteogenic differentiation than 
the others. (B) The morphology of the cultured cells was 
monitored under an inverted microscope. Data are presented as 
















Figure 33. Human ADSCs osteogenesis was induced either by routine protocol or by the protocol using 100 mg/ml of 
total protein until 2 weeks. (A) Significant (p<0.0001) model effect was detected and 1week, 2week conditioned media 
induced 40 fold more osteogenic differentiation than the others. (B) The morphology of the cultured cells was 







Figure 34. Human ADSCs osteogenesis was induced either by 
routine protocol or by the protocol using under 100 mg/ml of 
2weeks conditioned media total protein (10 mg/ml, 20 mg/ml, 50 
mg/ml) until 2 weeks. (A) Significant model effect was not 
detected among the group (p=0.1549), but induced more 
osteogenic differentiation trend in 50 mg/ml conditioned media 
adding group.  (B) The morphology of the cultured cells was 
monitored under an inverted microscope. Data are presented as 







media total protein until 9 days and 2 weeks. At 9 days 
differentiation, significant model effect was not detected among 
the group (p=0.1314), but induced more osteogenic 
differentiation trend in differentiation conditioned media adding 
group. And 2 weeks differentiation assay, significant model 
effect was detected (p=0.0241) (Fig. 35, 36). These 
observations indicate that morphogenetic factors also enhance 
osteogenic differentiation of ADSCs and can be substituted role 
of dexamethasone.  
 
Only effect of conditioned media by the modified protocol on 
Osteogenic differentiation  
 
Directing osteogenic differentiation without any 
exogenous cytokines, growth factors, and only insertion of 
conditioned media shows significant incensement (p=0.0142) on 
50ug/ml conditioned media only group (Fig. 37). 
This results indicated that the microenvironment produced 
during chicken bone marrow cells osteogenesis regulates the 
subsequent osteogenic differentiation of ADSCs, suggesting that 
soluble factors of cell secretion from bone marrow cells can 
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alternative significant roles in differentiation methods. Therefore, 
it can be utilized the morphogenetic signals from bone marrow 
cells during ADSCs reprograming into bone related tissue. 
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Figure 35. Human ADSCs osteogenesis was induced either by 
routine protocol or by the modified protocol which is without 
Dexamethasone and adding 100 mg/ml of each type of conditioned 
media total protein until 9days. (A) Significant model effect was 
not detected among the group (p=0.1314), but induced more 
osteogenic differentiation trend in differentiation conditioned 
media adding group. (B) The morphology of the cultured cells 
was monitored under an inverted microscope. Data are presented 

















Figure 36. Human ADSCs osteogenesis was induced either by 
routine protocol or by the modified protocol which is without 
Dexamethasone and adding 100 mg/ml of 2weeks differentiation 
conditioned media total protein until 14days. (A) Significant 
model effect was detected (p=0.0241). (B) The morphology of 
the cultured cells was monitored under an inverted microscope. 














Figure 37. Human ADSCs osteogenesis was induced either by routine protocol or by the modified protocol which is 
without any type of inducing chemicals and only adding 2weeks differentiation conditioned media total protein as 
10ug/ml, 20ug/ml, 50ug/ml until 14days. (A) Significant model effect was detected (p=0.0142) on 50ug/ml conditioned 
media only group. (B) The morphology of the cultured cells was monitored under an inverted microscope. Data are 













This study was conducted to examine the effect of 
chicken bone marrow cell-derived, bioactive substances on 
osteogenic differentiation of human adipose tissue-derived 
stromal cells (hADSCs).  
 
Over the past few years, many study groups have studied 
using conditioned media to evaluate efficiency as a generative 
biomarker. Released protein from conditioned media by cultured 
cells is a rich source of materials for biomarker as an application 
of novel treatment (Xue et al., 2008). Useful proteins released 
from cells culture medium can be used as novel bio-active 
substances to apply for the disease or regenerative treatment 
effects. This technique provides a useful, easy and effective 
method for discovering new biomarkers. The point here is that 
protein analysis is enhanced due to finding identification of 
biomarker candidate in which grown serum-free culture 
conditions (Righetti et al., 2003). Protein found in the medium 
controlled by the cell lines will come from cells through many 
different channels. The development of mass spectroscopy (MS), 
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unlabeled techniques, LC systems, and biometrics approaches 
had a profound impact on protein dynamics (Wong et al., 2009). 
These advances, combined with analysis of conditioned media, 
will undoubtedly facilitate identification of candidate biomarkers 
in cell culture environments. 
 
The standard procedure for the osteogenic differentiation 
of mesenchymal stem cells is addition with dexamethasone 
(Dex), ascorbic acid (Asc) and β-glycerophosphate (β-Gly). 
Osteogenic differentiation protocols using these three chemicals 
are frequently used for many experimental studies, including 
tissue engineering or detection of differentiation capabilities of 
particular cell types. These complex chemical mechanisms 
involved in osteogenic differentiation of stem cell cultures under 
the influence of Dex, Asc and β-Gly. Dex, Asc and β-Gly 
orchestrate several regulatory mechanisms during the 
differentiation process and does not start with an initial 
differentiation that if any insufficient. In some reports, Dex 
prevents apoptosis of BMSCs in confluent cultures (Song et al., 
2009) and promotes mesenchymal stem cell proliferation (Wang 
et al., 2012). In osteogenic differentiation, Dexamethasone acts 
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as a key molecule to differentiate into osteogenic lineage. FHL2 
signaling is a critical signal in the osteogenic differentiation of 
BMSCs and that Dexamethasone induces osteogenesis through 
the upregulation of FHL2 expression (Hamidouche et al., 2008). 
Then FHL2 induces the upregulation of the key transcription 
factor Runx2. Furthermore, Dexamethasone induces 
upregulation of TAZ, which binds to Runx2 (Hong et al., 2009). 
Additionally, Dexamethasone further induces osteogenic 
differentiation is the modulation of Runx2 phosphorylation 
through MKP-1 (Langenbach and Handschel, 2013). Ascorbic 
acid facilitates osteogenic differentiation by increasing the 
secretion of Collagen type I, as the binding increases integrin α
2β1 to Col1 (Kishimoto et al., 2013). This signal pathway 
increased phosphorylation of ERK1/2 in the MAPK signaling 
pathway and then PERK1/2 moved into the nucleus, where it 
binds to Runx2 and increase the osteogenic related lower signals 
then make expression of osteogenic proteins (Chaudhary and 
Avioli, 2000). β-Glycerophosphate increases osteogenic 
differentiation by the phosphorylation of ERK1/2 (Langenbach 




The results of this experimentation suggests that certain 
substrates secreted by chick sox9 positive cells stimulate 
osteogenic differentiation of hADSCs. But in this results have the 
unresolved questions of the identity of key morphogenetic 
factors influencing osteogenic differentiation of ADSCs. 
Identification of specific an key morphogenetic factors promoting 
ADSCs differentiation may elucidate mechanisms of leading to 














In this study, I investigated an establishment of scale-up 
culture environment of chicken sox9 positive cell and the 
characterization of putative bioactive substance of cell secretion. 
The above results clearly demonstrated under the established 
culture regimen used in the present study, the culture of neonatal 
chicken bone marrow tissue yielded cuboidal cell- dominant 
populations. The isolated bone marrow cells characterization and 
cellular activities differs in many ways from that of mammalian 
bone marrow cells, which usually exhibit a fibroblast cell –
dominant morphology (Toma et al., 2001; Bosnakovski et al., 
2005; Roson-Burgo et al., 2014). Then examine the effect of 
chicken sox9 positive cell -derived, bioactive substances on 
osteogenic differentiation of human adipose tissue-derived 
stromal cells (hADSCs). I sought certain substrates secreted by 
chick sox9 positive cell stimulate osteogenic differentiation of 
hADSCs using the chicken sox9 positive cell and their culture 
systems, based on the ease of manipulation and their expansion. 
 
As described in chapter 3-4, The results of this study clearly 
demonstrate that bone marrow tissue of neonatal chicks was 
premature at least up to 4 days after hatching. This tissue 
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contains a variety of cells involved in endochondral ossification 
as well as mature bone marrow cells. The majority of these cells 
became cuboidal until the end of primary culture, and more than 
80% of cells were Sox9-positive. The results of the 
differentiation induction suggest the feasibility of Sox9 for 
regenerating bone marrow tissues. 
Despite a mixed cell population, most cells collected at 
the end of P5 were Sox9-positive. Subculture of chick bone 
marrow cells may enable the vigorous proliferation of Sox9-
positive cells. Although a quantitative analysis was not 
performed, RT-PCR results demonstrated that Sox9 expression 
in P0 cells was weaker than that in P5 cells. Otherwise, a mixed 
culture of Sox9-positive cells with other cells may increase their 
action when they are co-cultured at least up to five times, and 
the culture of premature bone marrow cells can trigger certain 
cells with a specific function. These hypotheses are supported 
by this finding that the proliferation of endothelial cell- and 
macrophage-specific CD31-positive cells was strongly 
enhanced, and that all osteogenesis- and chondrogenesis-
related markers were expressed until P5. And two major findings 
were derived from the results of this study. First, the subculture 
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of neonatal bone marrow cells specifically amplifies both Sox9- 
and Col II-positive cells, which resulted Sox9-positive cells 
became dominant in the P5 cells, switching from the Col I 
dominant in nBMCs at the P0. Intact nBMCs contained 
considerable number of Sox9-positive cells (30% of total), but 
no Col II-positive cells were detected. Second, use of 
DMEM/F12 medium could optimize the outcome of nBMC 
subculture, which further contributed to customizing nBMC-
mediated, differentiation protocol for both osteogenesis and 
chondrogenesis 
Different culture systems may be specific to the 
proliferation of a specific cell type. The positive role of the 
culture system employed in this study in amplifying 
osteochondrognic cells was confirmed. The chick sox9 positive 
cell established in this study directed their differentiation 
towards osteogenesis and chondrogenesis, not adipogenesis, 
which confirmed their specific expression for 
osteochondrogenesis-related genes and markers. Taken 
together with the results of histological, molecular, and 
cytological analyses, these results suggest the potential use of 
chick sox9 positive cell as a basic biomaterial for clinical 
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applications for injuries and degenerative diseases (Barry and 
Murphy, 2004; Dezawa et al., 2005; Nandoe Tewarie et al., 2006; 
Kassem and Abdallah, 2008). 
 
In Chapter 5 and 6, I focused the confirm the 
effectiveness of basic fibroblast growth factor (bFGF) and 
different culture systems for expanding chicken bone marrow-
derived cells (BMCs). Basic fibroblast growth factor (bFGF) is a 
member of the FGF family and is a critical component of stem 
cell culture field(Sotiropoulou et al., 2006; Colenci et al., 2014). 
However, the role and optimized concentration of bFGF on 
promoting the proliferation of MSCs derived from chicken bone 
marrow (BM) has not been reported. Then the above results 
clearly demonstrate that under the regimen used in the present 
study, the culture of newborn chicken bone marrow tissue 
yielded both stromal and cuboidal cell- dominant populations. 
The culture of chicken bone marrow cells differs in many ways 
from that of mammalian bone marrow cells, which usually exhibit 
a fibroblast-like, stromal cell morphology (Toma et al., 2001; 
Bosnakovski et al., 2005). The retrieved cells using PGC medium 
were maintained up to at least the third passage, and a number 
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of differences in cell specific protein expressions were observed 
compared with our optimized cultured environments. 
From this results, bFGF is responsible for the 
proliferation of chicken sox9 positive cell but the underlying 
molecular regulatory mechanism are still not well understood and 
thus need further study about the proliferation related specific 
antibodies. In example of study using MSCs, bFGF treatment will 
induce condrogenesis and osteogenic differentiation (Chiou et al., 
2006; Ito et al., 2008; Kim et al., 2011). Osteogenic 
differentiation was significantly incensement (p<0.0001) 
detected on insertion of more 5ng/ml bFGF and chondrogenic 
differentiation was apparently detected on addition of 1mg/ml 
bFGF. In migration and invasion assay, exposure of 5ng/ml bFGF 
improved each activity. In conclusion, this study suggests that 
addition of 5 ng/ml bFGF in vitro on chick sox9 positive cell have 
effectiveness on proliferation, differentiation, migration and 
invasion ability. And the PGC culture environment acts as 
exhibited better proliferation than the optimal compositions of 
sox9 positive population during culture. And stromal cell marker 
like CD44 is expressed on only PGC medium culture environment. 
Chicken bone marrow cells have different characteristics 
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compared with bone marrow cells of mammalian species, which 
usually yield a fibroblast-dominant population. Considering the 
mixed population of bone marrow cells, a different regimen may 
be needed for the outgrowth of chicken bone marrow-derived 
fibroblasts. Modification of the regimen used for the culture of 
bone marrow cells from mammals is necessary for the outgrowth 
of fibroblasts. In any case, the results of this study will make it 
possible to characterize chicken bone marrow cells of various 
types further and will increase the feasibility of using chicken 
bone marrow cells for different applications. 
 
 In chapter 7, I was conducted to examine the 
effect of chicken sox9 positive cell -derived, bioactive 
substances on osteogenic differentiation of human adipose 
tissue-derived stromal cells (hADSCs). In this study, I 
demonstrate that morphogenetic signals from chicken bone 
marrow cells, in the form of soluble factors, induce as osteogenic 
differentiation enhancer of human ADSCs during in vitro 
differentiation. This results suggest possibility of the conditioned 
media as the morphogenetic factors from sox9 positive cell to 
differentiation induction agents or reprogram cells for in vivo 
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bone tissue engineering applications. ADSCs expanded in chicken 
sox9 positive cell derived osteogenic differentiation conditioned 
medium enhanced osteogenic differentiation compared by routine 
protocol method. In addition, incubation of ADSCs with 
conditioned medium supplemented with osteogenic factors or by 
oneself induced more osteogenesis and accumulation of calcium 
and increased ALP activity. These findings reveal that chicken 
sox9 positive cell derived secretion factors promote 
osteogenesis of ADSCs during in vitro differentiation culture.  
Given the current inefficient in vitro human cell differentiation 
protocols, this method and results develop a simple and 
innovative differentiation method for generating in vivo bone 
tissue from adult stem cells. 
 
Future studies are needed to reveal the unresolved 
questions of the identity of key morphogenetic factors 
influencing osteogenic differentiation of ADSCs. Identification of 
specific a key morphogenetic factors promoting ADSCs 
differentiation may elucidate mechanisms of leading to skeletal 
development. Through these future studies, new knowledge will 
be gained to overcome shortcomings growth factor or gene 
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deliveries for instructive signals or other efficient factors. Given 
the current inefficient in vitro human cell differentiation protocols, 
this method and results develop a simple and innovative 
differentiation method for generating in vivo bone tissue from 
adult stem cells. 
 
 In conclusion, I have verified that chicken bone marrow 
derived cells are different morphology and also cell 
characterizations, differentiation ability. And I establish culture 
condition of chicken bone marrow derived cells related cell 
proliferation and differentiation using DMEM/F12 + 5ng/ml bFGF. 
Then I explored the effect of chicken sox9 positive cell-derived, 
bioactive substances on osteogenic differentiation of human 
adipose tissue-derived stromal cells (hADSCs). The results 
obtained from this study have implications for the understanding 
of chicken sox9 positive cell and their difference suggests how 
it could be a newly alternative medicines. And it brings advances 
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SUMMARY IN KOREAN  
 
본 논문에서는 닭 골 및 연골 전구세포 (Chicken sox9 
positive cell) 의 최적화된 배양 환경 및 조건을 확립함으로써 회수
된 세포의 효율적인 조작 기법 및 대량 배양 시스템을 구축하였다. 
포유류 골수 유래 세포의 형태학적 및 세포 특성과 뼈의 성장능에
서의 차이를 토대로 닭 장골 유래 세포에 대한 배양 환경 탐색 및 
이를 통한 세포 이용 재생의학 분야로의 응용 방안에 대하여 고찰 
하였다. 
 
먼저 Chapter 4 에서, 4일령 병아리에서 회수된 세포에 대
한 특성 검증을 실시하였다. 일련의 실험 결과를 토대로 4일령 병아
리에서 회수된 골수 유래 세포는 전반적으로 입방상피세포의 형태
를 나타내고 있으며, 4일령 병아리의 장골의 단면을 염색한 결과 성
장판 및 제 2차 골 중심 부위가 형성 되지 않음을 확인 할 수 있었
다. 또한 골/연골 전구 세포의 활발한 증식 및 포유류와 비교하여 
장골 발달 단계에서의 차이를 확인 할 수 있었다. 다양한 세포 특이 
마커 발현 테스트를 통하여 회수된 세포는 골/연골 전구 세포인 
sox9 positive 세포임을 확인 하였다. 또한 Chapter 5, 6에서, 회수
된 세포에 대한 골 및 연골 세포로의 성장 및 발달 그리고 분화능
에 따른 배양 환경을 탐색하였다. 이 결과를 토대로 DMEM/F12를 
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이용한 기본 배양 조건에 5 ng/ml의 bFGF 첨가는 세포 특이 마커 
발현 및 성장능, 분화능이 우수함을 확인할 수 있었다. Chapter 7에
서는 4일령 골수 유래 세포에서의 전능성 및 줄기세포 관련 유전자
의 증폭 및 줄기세포 유사 세포의 회수를 위하여 배야 줄기세포 배
양 환경과 유사한 PGC 배양 배지를 도입하였다. 그 결과, CD44를 
포함한 기질 세포 마커가 발현 됨을 확인하였으며, 이 결과를 토대
로 4일령 병아리 골수에서 줄기세포 관련 특성을 갖는 세포의 배양
을 성공하였고 최적화된 배양 환경을 구축하였다. 마지막으로 
Chapter 8에서 sox9 positive 세포를 이용한 세포 분비 유래 유용 
물질 탐색을 실시 하였다. 회수된 닭 sox9 positive 세포를 골 분화
를 유도한 후 배양 배지에서 세포 분비 유래 물질을 농축 후 인간 
지방 유래 중간엽 기질 세포에 분화유도제로 사용하였다. 그 결과, 
일반적인 분화 유도 환경에서 보다 유의적인 차이를 보였으며 분화 
유도에 관련된 물질을 대체 함과 동시에 분화 유도에 단독 처리만
으로도 골 분화능이 있음을 확인하였다. 
 
골수 유래 세포는 중간엽 줄기세포를 포함한 다양한 여러 
세포들을 함유 하고 있으며, 우리 인체의 면역계 관련 세포를 함유
하는 중요한 세포로써 치료에 접목 가능한 보건 의료적, 산업적 가
치가 큰 세포이다. 본 논문에서 수행한 닭 장골 유래 sox9 positive 
세포의 배양 조건 확립과 체외 배양 기술은 골수 내 기능성 세포 
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및 골수 구성 세포들을 활용한 치료 기술에 접목 될 수 있으며, 성
장 관련 질병 및 세포 치료를 이용한 다양한 임상 분야에 기여 할 
수 있는 중요한 선도 기술이 될 것으로 사료된다.  
 
앞으로의 추가 연구를 통해 회수된 세포에서 분비되는 물질
에 대한 정확한 양적 동정 및 유용 물질에 대한 선별된 동정 과정
을 통해 추가적인 분비 물질을 이용한 치료 접목 분야에 관한 가능
성을 밝혀 낼 수 있을 것이다.  
  
